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1 Summary 
Correct propagation of the genetic information to the daughter cells is a central step in 
life. Structural maintenance of chromosomes (SMC) proteins support this process as 
key players in higher-order chromosome architecture in all organism. They form the 
core of several multi-protein complexes that are involved in sister chromatid cohesion, 
chromosome condensation and DNA repair. For their function ATP binding and 
hydrolysis is essential. 
In this work structural and biochemical studies were performed to understand the 
mechanism how SMC proteins fulfill their biological role. The crystal structure of the 
ATPase domain from Pyrococcus furiosus SMC (SMCcd) was determined in the 
nucleotide free form, in the presence of ATP and two transition state analogues. ATP 
mediates the dimerization of two SMC ATPase domains by binding to opposing 
Walker A and signature motifs, indicating that ATP can directly assemble SMC protein 
rings. The dimerization of the head domains could be proved biochemically. 
Comparison of the four obtained SMCcd structures revealed only minor structural 
changes during the ATPase cycle indicating that no “power stroke” is involved in the 
function of SMC proteins. 
The largest conformational changes occur at a surface loop that is ordered upon ATP 
binding. Structural and mutagenesis data identified an arginine residue in this loop that 
is conserved among all SMC proteins. This arginine finger links a putative DNA 
interaction site on the surface of the SMC protein to the bound ATP and stimulates its 
hydrolysis. The importance of the connection between DNA interaction and ATP 
hydrolysis for the biological function of SMC proteins could be proved together with a 
collaborating group. 
SMCcd was also used to gain insights into the mechanism of the adenylate kinase 
activity of ABC ATPases. The crystal structure of SMCcd in complex with the 
adenylate kinase inhibitor AP5A suggests that ATP binds to the P-loop while AMP 
binds to the Q-loop glutamine. Furthermore, the adenylate kinase reaction probably 
occurs in the engaged dimer and requires the signature motif. These findings indicate 
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that ATP hydrolysis and adenylate kinase activity of ABC ATPases are achieved by the 
same set of conserved motifs enabling both reactions in one protein. Different ABC 
ATPases developed mechanisms to favor one or the other reaction for their biological 
function. 
Taken together this thesis revealed important insights into the mechanism of SMC 
proteins. The obtained results mark powerful starting points for further experiments on 
the biological function of SMC proteins. Mutational analysis of the arginine finger 
discovered in this work was already used to dissect the establishment of sister 
chromatid cohesion in vivo. Furthermore, it could be shown that the ability to catalyze 
the adenylate kinase reaction is probably an intrinsic ability of all ABC ATPases. 
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2 Introduction 
2.1 The ABC ATPase family 
ABC-type ATPases are ubiquitous in all kingdoms of life and are characterized by the 
conserved ATP-binding cassette (ABC). Originally this type of nucleotide binding 
domain was described in transmembrane proteins using the energy of ATP hydrolysis 
to transport various substrates from ions to proteins across the membrane. The histidine 
permease was the first representative of this family described in 1982. Other notable 
examples are the P-glycoproteins (MDR-1 and MDR-2) which are over-expressed in 
tumor cells leading to resistance of the cells against chemotherapy., the vitamin B12 
transporter from E.coli and the yeast mitochondrial ABC transporter Mdl1 involved in 
peptide transport (Bradley et al., 1988; Higgins et al., 1982; Locher et al., 2002; Young 
et al., 2001). ABC transporters share a conserved central architecture of two 
transmembrane domains (TMD) and two nucleotide binding domains (NBD) to which 
additional functional domains might be added. The transporters can be encoded by one 
gene for all four subdomains, two domains can be fused (TMD-NBD, TMD-TMD or 
NBD-NBD) or all subdomains are encoded by a different gene. ABC transporters can 
function as importers or exporters. Importers need an additional substrate binding 
protein that allocates the substrate to be functional (Oswald et al., 2006). The TMDs 
form the translocation tunnel and are very diverse in sequence thereby affording the 
broad range of transported substrates. The NBDs or ABC domains contain the 
conserved motifs for ATP binding and hydrolysis. Beside the high sequence homology 
the NBDs from different ABC ATPase proteins show structural similarity as seen in 
various high resolution structures obtained over the last years (for examples see Fig. 1). 
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Figure 1: Structures of ABC ATPases. 
Ribbon representation of high resolution structures of ABC proteins obtained by X-ray 
crystallography. The two NBDs are colored in dark and light blue, additional domains in dark and 
light red. Nucleotides are depicted as spheres and DNA bound to MutS as sticks. The upper part 
shows the structures of BtuCD (PDB ID: 1L7V) and of a bacterial multidrug transporter (PDB ID: 
2HYD). The predicted position of the membrane is indicated with dashed lines. The bottom row 
shows structures of ABC proteins not involved in cross membrane transport: the DNA mismatch 
repair enzyme MutS with bound DNA (PDB ID: 1E3M), in the middle ABCE1 (PDB ID: 1YQT) 
and Rad50 (PDB ID: 1II8 / monomer structure arranged as dimer for better comparison). 
 
To obtain a functional active site two NBDs have to dimerize “head-to-tail“ upon 
binding of ATP. This brings the ABC ATPase motifs of two NBDs together, forming 
two active sites each binding one ATP (Fig.1 and 2) (Hopfner et al., 2000; Obmolova et 
al., 2000; Smith et al., 2002). 
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Figure 2: Conserved ABC ATPase motifs. 
A) Ribbon representation of the Rad50 dimer with bound AMP-PNP as color coded sticks, the 
Mg2+ (magenta), the putative nucleophilic water and the 2 waters coordinated by the Mg2+ as 
spheres (PDB ID 1F2U). Functional motifs are colored as in C. B) Table listing the functional 
ABC ATPase motifs with their consensus sequence and the proposed function. X stands for any 
and Φ represents a hydrophobic amino acid. C) Stereo view of one active site of dimeric Rad50 
with annotated motifs in the same representation as in A. 
 
Among the functional motifs the Walker A motif or P-loop is the major ATP binding 
site. The Walker B motif is involved in ATP hydrolysis (Walker et al., 1982). The third 
highly conserved motif is the C-loop or signature motif. This loop with the consensus 
sequence LSGGQ/E is located distant from the Walker motifs in the three dimensional 
structure of the NBD. In the biological relevant dimer, however, it forms a composite 
active center with the Walker motifs of the second NBD (Fig. 2). By formation of 
specific hydrogen bonds of the serine and glycine residues to the γ phosphate, the 
function of this motif can be described as a specific γ phosphate sensor (Hopfner et al., 
2000). The P-loop and signature motif are located at the N-termini of two helices and 
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compensate the increased negative charge during ATP hydrolysis (Fig. 3). The D- and 
Q-loop are involved in binding the active site ion and activating the attacking water 
molecule. This nucleophil is positioned and activated together with the H-loop form the 
opposing NBD, therefore hydrolysis can only take place in an engaged dimer. 
A B
 
Figure 3: Mechanism of ABC ATPases. 
A) The ribbon model of ATP-bound Rad50 that the two NBDs dimerize head to tail and form two 
composite active sites. The P-loop of one domain and the signature motif of the other compensate 
the phosphate charge being located at positively charged N-termini of the highlighted helices (red 
and blue). B) ATP binding to the interface of two NBDs of ABC ATPases leads to rearrangement 
of the P-loop and signature helices (same color as A), causing domain engagement and 
conformational changes are conducted to the substrate binding domains (Hopfner and Tainer, 
2003). 
 
A second catalytic activity besides the ATP hydrolysis was described for the cystic 
fibrosis transmembrane conductance regulator (CFTR). The CFTR protein, whose loss 
of function leads to the cystic fibrosis disease, is structurally related to the ABC 
transporters and serves as an anion channel (Riordan et al., 1989). In the presence of 
ATP the isolated NBD2 of CFTR displays ATPase activity but the addition of AMP to 
the reaction leads to formation of ADP in an adenylate kinase reaction (ATP + AMP ? 
ADP + ADP) (Fig.4). This adenylate kinase activity was suggested to regulate the 
channel opening for the passive flux of the ions instead of control gating via the highly 
energy consuming ATPase reaction. (Gross et al., 2006; Randak and Welsh, 2003). 
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Figure 4: Model of the adenylate kinase activity of CFTR. 
This illustration shows a cartoon of the CFTR-NBD2 with hypothetical ATP- and AMP-binding 
sites. The indicated reversible adenylate kinase reaction is inhibited by AP5A, a bisubstrate 
inhibitor (Randak and Welsh, 2005). 
 
The ABC-type ATPase domain is also found in a variety of proteins not involved in 
transport across membranes. For example in the ABCE1 protein (RLI / HP68) which is 
one of the most conserved proteins among species. This protein shows a unique 
arrangement of the ABC domains. It comprises two NBDs on a single polypeptide 
chain linked by a hinge domain and contains two additional 4Fe4S cluster (Fig. 1). The 
fundamental cellular function of this protein which makes it essential in all types of 
organism is not known so far, but it is supposed to play a role in translation (Bisbal et 
al., 1995; Karcher et al., 2005; Zimmerman et al., 2002). 
Another interesting non-transporter ABC protein is the DNA mismatch repair enzyme 
MutS (Fig. 1). MutS forms homodimers in prokaryotes and heterodimers in eukaryotes 
and is responsible for the recognition of DNA mismatches. After sensing the mismatch 
MutS activates MutL in an ATP dependent manner while MutL is stimulating the 
endonuclease activity of MutH. (Hopfner and Tainer, 2000; Jun et al., 2006; Lamers et 
al., 2000; Obmolova et al., 2000; Sixma, 2001).  
UvrA, a protein involved in nucleotide excision repair, also contains ATPase domains 
of the ABC type. Although the actual mechanisms of damage recognition, signaling 
and repair conducted by the UvrABC machinery is not completely dissected so far, 
ATP binding to UvrA and subsequent dimerization are essential for the repair process 
(Husain et al., 1986; Oh et al., 1989; Van Houten et al., 2005). 
The central protein of the Rad50-Mre11 complex which is involved in double strand 
break repair is also a member of the ABC ATPase family. Rad50 is characterized by an 
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ABC ATPase domain from which a long coiled-coil protrudes that may serve as a 
linker between different DNA strands. This protein was the first case where the 
question of the dimerization mode of ABC ATPases could be answered by a high 
resolution structure. The structure of the NBD from Pyrococcus furiosus Rad50 with 
bound ATP revealed the biological relevant “head to tail” dimeric state (Hopfner et al., 
2000). 
An important subfamily of the ABC ATPases is the structural maintenance of 
chromosomes (SMC) protein family, containing proteins structurally related to Rad50 
which play an essential role in genome integrity. 
2.2 The SMC protein family 
Cell division is one of the most crucial processes for living cells. The genetic 
information has to be handed over faithfully to the daughter cells during division. Key 
players involved in this process are protein complexes with SMC proteins as central 
component. SMC1 was the first protein of the SMC family discovered in 1985 in a 
mutant yeast strain with impaired maintenance of artificial centromeric 
minichromosomes (Larionov et al., 1985). Derived from this function the gene was 
named Stability of Mini Chromosomes. After the discovery of other proteins sharing 
sequence and structural homology but other functions the name was generalized to 
Structural Maintenance of Chromosomes. Members of the SMC protein family are 
ubiquitous in all kingdoms of life emphasizing their importance for genome integrity. 
In eukaryotes six SMC proteins are known so far, which form the core of different 
complexes involved in chromosome condensation (SMC2+4), sister chromatid 
cohesion (SMC1+3) and DNA repair (SMC5+6). Bacterial and archaeal genomes have 
only one gene for a SMC protein and so far not much is known about the different 
complexes they might form. According to the mostly accepted model SMC proteins 
associate with other proteins, forming large proteinous rings that entrap the DNA one 
or several times to fulfill their function. 
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2.2.1 Architecture of SMC proteins 
Members of the structural maintenance of chromosomes (SMC) family share a 
characteristic domain structure. The 1000 to 1300 residues long polypeptide chain folds 
into an elongated three domain protein. The N- and C-terminal parts are forming a 
globular head domain, the middle part folds into a globular hinge domain and a long 
coiled-coil joins both domains. 
B
C
D
N C
A
head   - coiled-coil  - hinge  - coiled-coil   - head
ATPase                      dimerization                       ATPase
 
Figure 5: Architecture of SMC proteins. 
A) Domain organization of SMC proteins. B) Electro micrographs of S. cerevisiae SMC1/3 dimer 
(Haering et al., 2002). C) Electro micrographs of B. subtilis SMC homodimers (Melby et al., 
1998). D) Model of a SMC dimer (Losada and Hirano, 2005). 
 
SMC proteins belong to the ABC group of ATPases with all typical motifs located at 
their head domain formed by the N- and C-terminal parts of the protein. Structural 
analysis of the Thermotoga maritima SMC head domain revealed high structural 
similarity to other members of the ABC ATPase family such as Rad50 catalytic 
domain, MukB N-terminal domain and histidine permease ATP binding domain (Lowe 
et al., 2001). To form a catalytically active ATPase site, it has been proposed that two 
head domains have to dimerize upon ATP binding to form a composite active center as 
shown for Rad50 (Hopfner et al., 2000). This idea is supported by different 
biochemical and structural analysis on SMC proteins over the last years. For the 
activity of SMC proteins ATP binding and hydrolysis capacity is essential (Hirano and 
Hirano, 1998; Kimura and Hirano, 2000). 
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The coiled-coil domain protruding from the head domain consists of two anti parallel 
helices and is ~ 500 Å long. This remarkable structural feature allows SMC proteins to 
span over a distance equivalent to ~ 150 bp dsDNA. Besides this more structural 
property at least the coiled-coil of SMC1 has a functional role in DNA damage 
response. SMC1 contains two serine residues (957 and 966 in human) in a non-helical 
region of the coiled-coil close to the head domain. It was shown that these residues are 
phosphorylated in vitro and in vivo by the checkpoint kinase ATM after ionizing 
radiation and ATM independently after other DNA damaging events. The 
phosphorylation of SMC1 in response to DNA damages and S-phase checkpoint 
activation underlines the central role of SMC proteins in genome maintenance (Kim et 
al., 2002; Kitagawa et al., 2004; Wakeman et al., 2004; Yazdi et al., 2002). 
At the end of the coiled-coil the two helices fold back on each other, forming the hinge 
domain. Two SMC proteins associate via this hinge, forming a V-shaped heterodimer 
in eukaryotes and homo dimer in prokaryotes as seen in electron micrographs (Fig. 5B). 
The crystal structure of the T. maritima hinge domain reveals a dimer with coiled-coils 
protruding from the same site of the molecule which is consistent with a V-shaped 
molecule (Fig. 6A)(Haering et al., 2002).  
A
B
 
Figure 6: The SMC hinge domain. 
A) Crystal structure of the dimeric T. maritima hinge domain (Haering et al., 2002). B) Model for 
the entry of DNA into the SMC1/3 complex via the hinge domain (Gruber et al., 2006). 
 
The importance of the dimerization via the hinge domain is emphasized by mutational 
analyzes in which mutation impeding dimerization of B. subtilis SMC proteins abolish 
their interaction with DNA (Hirano and Hirano, 2002). Furthermore, it was observed 
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that the hinge domain of B. subtilis is able to interact with DNA, thereby stimulating 
the ATPase activity (Hirano and Hirano, 2006). Additionally, it was shown that SMC 1 
and 3 can no longer associate with DNA, when connected via an artificial hinge. Based 
on these findings a model was proposed where the DNA enters the SMC ring through 
the hinge domain by stepwise opening of the hinge (Fig. 6B) (Gruber et al., 2006). 
Different complexes between SMC proteins and various non-SMC proteins result in 
different cellular functions. An overview of the complexes is shown in figure 7. The 
relationship between the names for the proteins in different eukaryotes is given in table 
1 of the appendix. 
 
Figure 7: Subunit composition of SMC protein complexes. 
Architecture and composition of the different SMC protein complexes described in sections 2.2.2 
to 2.2.5 (Losada and Hirano, 2005). 
2.2.2 The SMC 1/3 cohesin complex 
The best characterized SMC protein complex is the cohesin complex consisting of 
SMC1 and SMC3 and the non-SMC proteins SCC1 and SCC3. This complex holds the 
sister chromatides together till the onset of anaphase (Michaelis et al., 1997). For 
proper sister chromatid cohesion the SMC1/SMC3/Scc1/Scc3 complex has to be loaded 
in late G1 phase before DNA replication starts. The replication fork has then to slide 
either through the ring structure of the cohesion complex or the ring is somehow 
opened in front of the replication fork and is held in close proximity to be re-associated 
after passage of the replication machinery (Carson and Christman, 2001; Lengronne et 
al., 2006). For the association of the cohesion complex with chromosomes ATP 
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hydrolysis is absolutely essential and it was proposed that the entry door to the ring is 
perhaps the hinge region (Arumugam et al., 2003; Gruber et al., 2006; Weitzer et al., 
2003). The binding and loading of the preassembled cohesin complex is mediated by 
the Scc2/Scc4 protein complex that is associated to distinct regions of the 
chromosomes (Ciosk et al., 2000; Gillespie and Hirano, 2004; Takahashi et al., 2004). 
Additionally, the Eco1 and some other proteins are essential for establishing sister 
chromatid cohesion during S phase and couple cohesion to PCNA (proliferating cell 
nuclear antigen) dependent DNA replication (Skibbens et al., 1999; Toth et al., 1999).  
 
Figure 8: Model of the cohesin cycle in yeast. 
Cohesin (SMC in blue and red, non-SMC subunits in green) is loaded onto the chromosomes with 
the help of Scc2/Scc4 and sister chromatid cohesion is established by interaction of Eco1 with the 
replication fork. At anaphase onset cleavage of Scc1 by separase leads to ring opening and sister 
chromatid segregation (Nasmyth and Haering, 2005). 
 
From the area of loading the cohesion rings are relocated by the replication forks to 
places of convergent transcription (Lengronne et al., 2004). If the chromosomes are 
properly aligned on the mitotic spindle and no DNA damages are encountered the 
APC/C (anaphase promoting complex/cyclosome) marks securin for degradation by 
ubiquitylation. A protease called separase is no longer blocked by its inhibitor securin 
and cleaves the Scc1 subunit of the cohesin complex. The cohesin ring is open and the 
sister chromatides can be segregated to opposing poles of the cell (Fig. 8) (Uhlmann, 
2001; Uhlmann et al., 1999; Uhlmann et al., 2000). During meiosis Scc1 is replaced by 
Rec8, that is cleaved in the first division only distal to crossing over events, to allow 
Introduction 13 
 
 
 
segregation of homologues while the proximal complexes are cleaved only in the 
second meiotic division to allow sister segregation (Klein et al., 1999; Watanabe and 
Nurse, 1999). 
2.2.3 The SMC 2/4 condensin complex 
The core of the condesin complex is formed by SMC2 and SMC4. Together with three 
non-SMC proteins called CAP-D2, CAP-G and CAP-H in condensin I and CAP-D3, 
CAP-G2 and CAP-H2 in condensin II two different subtypes of condensin complexes 
are formed. The architecture of the functional complexes is similar to that of cohesion 
but their function is different. Condensin is responsible for the compaction of the 
chromosomes before cell division to obtain shorter and mechanically more stable 
chromosomes that can be handled by the cell (Hirano et al., 1997; Hirano and 
Mitchison, 1994; Steffensen et al., 2001). The condensin complexes are loaded onto the 
chromosomes during early mitosis where condensin II initiates the early stage of 
condensation and condensin I is recruited to the chromosomes after nuclear envelope 
break down (Gerlich et al., 2006; Hirano et al., 1997; Hirota et al., 2004; Kireeva et al., 
2004; Ono et al., 2003). How the compaction of the chromosomes is achieved in the 
cells is not clear so far. In vitro experiments could prove the introduction of positive 
supercoils into closed circular DNA in the presence of condensin complex, ATP and 
Topoisomarase I. This reaction is a good candidate for the condensation of DNA in 
vivo. The kind of interaction of the complexes with the chromosomes leading to 
superhelical torsion is however unclear. Condesin might form rings like cohesin, 
entrapping different regions of one chromatid, or it might form filaments that loop the 
DNA (Hagstrom et al., 2002; Hirano, 2006; Kimura and Hirano, 1997; Kimura and 
Hirano, 2000). 
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Figure 9: Working model of the condensin action. 
After binding of condesin (magenta: coiled-coil / hinge and yellow: head) to DNA intermolecular 
head-head interactions can lead to nucleoprotein filaments in which super helical tension is 
trapped (A) or chiral loops might be produced by intramolecular head-head engagement (B). In a 
next step protein-protein interaction could form rosette like structures that then stack to form the 
chromatin fiber (Hirano, 2006). 
 
A second role of condensin besides of the compaction of DNA for cell division seems 
to be the dosage compensation. The investigation of the dosage compensation complex 
in C.elegans revealed a high degree of homology to the composition of the condensin 
complex (Chuang et al., 1994; Lieb et al., 1998; Lieb et al., 1996). Dosage 
compensation via this complex might be achieved through compaction of the DNA 
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regions of the X chromosome with genes that are intended to be silenced (Martinez-
Balbas et al., 1995). 
2.2.4 The SMC 5/6 DNA repair compex 
The third SMC complex in eukaryotes was found in a genetic screen of a radiation-
sensitive S. pombe mutant (Nasim and Smith, 1975; Phipps et al., 1985). Rad18 / 
SMC6, the complementing gene product in this screen, dimerizes with SMC5 and 
forms together with the four non-SMC subunits Nse1-4 the functional complex. The 
whole complex is assembled by the binding of Nse2 to the coiled-coil of SMC5 and 
recruitment of a complex of Nse1, Nse3 and Nse4 to Nse2. This architecture is 
strikingly different from the two other complexes. Furthermore, two non-SMC proteins 
involved in the complex show functional motifs in their primary structure. Nse1 
contains a RING finger motif conserved in E3 ubiquitin ligases and Nse2 a zinc finger 
motif characteristic for SUMO ligases (Fujioka et al., 2002; McDonald et al., 2003). 
The importance of these activities for the complex function is underlined by the fact 
that mutations in the Nse2 RING finger impairing sumoylation of the other subunits 
and especially decreased level of SMC6 sumoylation lead to radiation sensitive but 
viable cells. Complete loss of any of the proteins involved in this complex leads to 
accumulation of DNA damages and abnormal structures in the cell over a few rounds of 
divisions and finally to cell death (Zhao and Blobel, 2005). An additional role of the 
SMC5/6 complex in segregation of repetitive chromosome regions was reported 
(Torres-Rosell et al., 2005). However, the distinct function of the SMC5/6 complex in 
DNA repair is not known so far but its involvement in the maintenance of genome 
integrity is definite. 
 
2.2.5 The bacterial SMC / Kleisin complex 
In bacteria and also archaea the core of the SMC complex is formed by a homodimer of 
SMC proteins. The non-SMC proteins of the functional complex are named ScpA and 
ScpB for “segregation and condensation protein” and at least the gene for ScpA can be 
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found in all bacteria. Deletion of either SMC, ScpA or ScpB in B.subtilis leads to 
disorganization of nucleoids, changes in superhelicity of plasmids and nucleoid 
partitioning effects and are finally lethal (Britton et al., 1998; Graumann, 2000; 
Graumann, 2001; Mascarenhas et al., 2002). The stoichiometry of the complex is not 
clear so far. ScpA is able to interact directly with the head domains of the SMC core 
whereas ScpB binds to ScpA. The subcomplexes themselves can multimerize so that 
the biological composition of the SMC-kleisin complex still has to be determined 
(Dervyn et al., 2004; Hirano and Hirano, 2004). Due to the fact that bacterial SMC 
proteins form homodimers especially B.subtilis proteins were used to investigate the 
mechanism of SMC proteins. Using this model it was found that dimerization of the 
hinge domain is essential for interaction with DNA (Haering et al., 2002; Hirano and 
Hirano, 2002). Furthermore, the activity of SMC protein complexes to bind and 
restructure DNA is depending on ATP binding and hydrolysis (Hirano and Hirano, 
1998). The ATPase activity itself is stimulated by interaction of DNA with the hinge 
region and is influenced by the kleisins (Hirano and Hirano, 2004; Hirano and Hirano, 
2006). 
2.2.6 The bacterial MukB/E/F complex 
MukB is the homologue of the SMC proteins in γ-proteobacteria (Melby et al., 1998; 
Niki et al., 1991). Although having no sequence similarities the structure and function 
is similar to that of SMC proteins. It also forms V-shaped homodimers connected by 
their hinge domains and is responsible for DNA condensation in complex with the non-
SMC proteins MukE and MukF (Niki et al., 1992; Yamanaka et al., 1996; Yamazoe et 
al., 1999). Knockout of any of the three proteins leads to inability to grow above 30°C, 
diffuse nucleids and high incidence of anucleate, elongated or filamentous cells 
(Sunako et al., 2001). 
2.3 Structure determination by X-ray crystallography 
The function of a protein is directly related to its three dimensional structure. To obtain 
insights into the three dimensional structure of a protein and thereby being able to link 
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its structure to its function, three different methods are available today. One method is 
electron microscopy with relatively low resolution around 10 down to so far ~4 Å, but 
it is applicable for big proteins and complexes. A second method is nuclear magnetic 
resonance spectroscopy (NMR) which is able to determine the atomic structure of small 
proteins in solution (usually around 30 kDa up to 50 kDa). The third technique is the 
structure determination by X-ray diffraction using protein crystals. This method can be 
used to obtain high resolution structures without size limitations. The latter method was 
used in this work and will be briefly described in the following section. For more 
detailed information several textbooks are available (e.g. (Blow, 2002; Drenth, 1999; 
McPherson, 2001)). 
2.3.1 Physical and mathematical background 
Two distinct points can only be recognized as individuals if the wavelength of the 
electromagnetic radiation used for observation is in the range of the distance of the two 
(Abbe limit). In the case of proteins this means that the wavelength has to be in the 
range of 1 Å corresponding to the typical bond length of e.g. 1.497 Å for a Cα-Cβ bond 
(Engh, 1991). Radiation with a wavelength between 0.1 and 10 Å is called X-ray 
radiation. For structure determination this high energy radiation is produced with 
rotating copper anodes or at synchrotrons. The interaction between X-rays and matter is 
very weak and so the prerequisite for structure determination using X-rays is the 
growth of protein crystals. In the crystal proteins are periodically repeated in a three 
dimensional lattice resulting in enough scattering power to be able to detect a 
diffraction signal. X-rays interact with the electrons of the proteins and are emitted in a 
sphere. The interference of the waves emitted from all electrons in the crystal lead to a 
distinct diffraction pattern with only a few regions of positive interference. These 
regions of positive interference are recorded as spots on a detector with their intensity 
and location. The reflections are related via the Bragg’s law (equation 1) to a set of 
parallel lattice planes in the reciprocal space and are classified by the Miller indices h, k 
and l.  
θλ sin2 ⋅⋅=⋅ dn  (1) 
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The scattered waves positively interfere and lead to detectable spots if the distance d 
and the angle θ between the plane and the incident beam fulfill this condition with n is 
an integer and λ the wavelength. 
The intensity of a reflection (hkl) is proportional to the square of the structure 
amplitude |Fhkl|. The structure factor F mathematically describes the scattering of the 
incident beam by the crystal (equation 2). 
[ ]  ⋅−⋅++⋅⋅= ∑= 2/2sinexp)(2exp1 λθπ j
N
j
jhkl BlzkyhxifF jjj  (2) 
The scattering power of a certain atom j with the coordinates (x,y,z) depends on the 
atom type and is described with the atomic scattering factor fj. Additionally the thermal 
disorder is taken into account by the B- or Debye-Waller factor (last term of the 
equation). 
Because X-ray waves are diffracted by the electrons of the atoms the structure factor is 
related to the repetitive electron density pattern of the crystal by a Fourier 
transformation (FT). Applying a Fourier synthesis one can calculate the structure 
factors out of the electron density. In the diffraction experiment one wants to determine 
the electron density of a protein from the diffraction pattern to model its structure. By 
measuring the intensities of the reflection one obtains the amplitudes of the structure 
factors |Fhkl|. Before an inverse FT (equation 3) can be applied to the structure factors 
their complex value has to be completed by the phases (α) which are lost during 
recording the reflections (equation 4). 
( )[ ]∑ ++⋅−⋅=
hkl
hklxyz lzkyhxiF
V
πρ 2exp1  (3) 
[ ]hklhklhkl iFF α⋅⋅= exp  (4) 
Obtaining this phase information is referred to as the “phase problem” in 
crystallography and can be achieved in different ways. If a structure of a similar 
molecule is known that model can be used to determine the phases by molecular 
replacement. De novo phasing procedures use the altered diffraction properties of heavy 
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metals for isomorphous replacement (SIR/MIR) or anomalous dispersion (SAD/MAD). 
The phasing methods used in this work are briefly described in the following chapters. 
2.3.2 Single- and multi-wavelength anomalous diffraction 
For normal diffraction experiments it is assumed that the emitted waves have the same 
phase and energy as the exciting beam (elastic scattering). The assumption that the 
scattering of the X-ray beam is elastic is only true to a certain extend because the 
electrons are not free oscillators but damped in an electric field and have an 
eigenfrequency. If the energy of the incident photons is close to this eigenfrequency of 
the electrons they can be absorbed and re-emitted at lower energy (fluorescence) or 
with altered phase (anomalous dispersion). If the absorption of a certain element is 
plotted against the energy of the X-ray beam the curve shows characteristic peaks at the 
so called absorption edges (Fig. 10). 
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Figure 10: Scattering factors as function of X-ray energy. 
The scattering factors f’ (red) and f’’ (black) of a typical selenium crystal are shown as functions 
of the X-ray energy. The energy / wavelength for diffraction experiments are indicated as pk: 
peak wavelength (maximal f’’-SAD+MAD); in: inflection point (minimal f’-MAD); lr and hr: low 
and high remote (anomalous contribution low-MAD). 
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At these edges the anomalous scattering is maximal whereas at lower and higher 
wavelength this contribution is minimal. Elements normally occurring in biological 
molecules such as carbon, nitrogen, oxygen do not have their absorption edges in the 
range of X-ray wavelengths used in diffraction experiments. For this reason heavy 
atoms (e.g. selenium, mercury, platinum) that have their transitions in the appropriate 
energy range are introduced into proteins to perform anomalous dispersion 
experiments. Because the actual energy where the transition occurs depends on the 
environment of the atoms the required wavelengths have to be determined for every 
experiment by a fluorescence scan. From this scan the values of f’’ are derived directly 
and are related to f’ by the Kramers-Kronig equation. 
'''''0 ffiffffano +=+∆+=  (5) 
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Figure 11: The atomic scattering factor. 
A) Atomic scattering factor f0 for a free electron. B) Anomalous atomic scattering factor fano of a 
bound electron with the anomalous contribution consisting of a real part ∆f and an imaginary part 
f’’. 
 
The anomalous diffraction results in a change of the atomic scattering factor that gains 
an anomalous contribution consisting of a real part ∆f and an imaginary part if’’ that is 
dependent on the wavelength (Fig. 11). This anomalous contribution to the scattering 
factors leads to the break down of Friedel’s law. In normal diffraction experiments the 
Friedel mates FP(hkl) and FP(-h-k-l) of a protein P have the same amplitudes but 
opposite phases. The imaginary f’’ contribution from a heavy atom H in an anomalous 
scattering experiment leads to a difference between FH(hkl) and FH(-h-k-l) and 
therefore in the whole FPH. 
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This difference ∆|FPH|ano (equation 6) between the now called Bijvoet pairs can be used 
to solve the heavy atom substructure by direct methods or using Patterson space.  
( ) ( )( )
''2
'
f
fFFF lkhPHhklPHanoPH ⋅−=∆ −−−  (6) 
A Patterson function calculated with the squared Bijvoet difference amplitudes should 
contain only peaks corresponding to interatomic vectors between pairs of anomalous 
scattering atoms. The interatomic vectors of symmetry related atoms give the highest 
peaks and lie on the Harker sections whose coordinates (uvw) are depending on the 
space group. Using these peaks the anomalous scatterer can be located in the unit cell. 
With the heavy atom substructure the phases αH and the whole structure factor of the 
heavy atoms are known. Together with the measured amplitudes for |FPH| and |FP| the 
phase contribution of the protein can be derived according to equation 7 and an electron 
density calculated by a FT. 
HHPPPH FFF αα ⋅+⋅=  (7) 
2.3.3 Molecular replacement 
If a three dimensional model is known that is similar (approximately 1 Å rmsd) to the 
structure this has to be solved one can use that model for obtaining initial phases. To 
calculate the phases the model has to be oriented in the unit cell corresponding to the 
molecule whose structure has to be solved. The search for this orientation is a six 
dimensional problem because three rotational and three translational parameters have to 
be determined. Using the Patterson function (equation 8) the rotation and the translation 
of the model can be decoupled and performed one after each other. 
( )[ ]lwkvhuiF
V
uvwP
hkl
hkl ++⋅−= ∑ π2exp1)( 2  (8) 
The calculation of the Patterson map for the rotational search is performed in an 
arbitrary large unit cell and only for peaks within a radius around the origin in the size 
of the model to eliminate intermolecular cross vectors. The remaining intramolecular 
self vectors are oriented on each other by the rotation function. The cross correlation 
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function of the calculated Patterson densities has a maximum if the model and the 
unknown structure are equally oriented in space. After the right rotation operators are 
found the translation function considering the cross vectors which have been excluded 
before is used to finally position the molecule in the unit cell. With the help of the 
correct positioned model the phases αcalc can be calculated. This phase information 
together with the measured amplitudes |Fobs| determines the structure factor F of the 
protein (equation 9). 
[ ]calcobs iFF αexp⋅=  (9) 
The phase information in this term is calculated with the help of a model that is 
different from the actual molecule and therefore bias the calculated electron density. To 
reduce this model error a weighted electron density map, e.g. a 2Fo-Fc map, is used for 
model building. Additional and missing parts can be assigned in the difference electron 
Fo-Fc density map. 
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3 Objectives 
Proteins of the structural maintenance of chromosomes (SMC) family play an 
important role in genome maintenance. They are present in all organisms and form the 
core of multiprotein complexes facilitating DNA repair and equal distribution of the 
genetic information onto the daughter cells. The current model presumes that the SMC 
proteins form large proteinous rings that trap the DNA to fulfill their function. For the 
cohesin complex it is known how the DNA is released from the ring during cell cycle 
but the question remains how the DNA enters the ring. Although it was shown that 
ATP binding and hydrolysis is essential for the function of SMC proteins its distinct 
role remained unclear. 
To gain insights into the mechanism of SMC proteins on molecular level the aim of this 
work was to clone, express, purify and crystallize the nucleotide binding domain 
(NBD) of an archaeal SMC protein. The role of ATP binding and hydrolysis should be 
clarified by crystallizing the NBD in presence of ATP and transition state analogues. 
Furthermore, after examination of the protein structure the role of important residues 
for biological function should be confirmed by in vitro assays of wild type and mutant 
protein. Possible non-SMC subunits of the archaea should be identified, cloned and 
expressed to study their influence on the biochemical activity of the NBD. Furthermore, 
the question whether DNA-binding modulates the activity of the SMC proteins should 
be addressed. 
The protein should also be used to gain structural insights into the puzzling adenylate 
kinase activity described for the CFTR protein. This protein belongs to the family of 
the ABC ATPase as the SMC proteins do and therefore possess the same functional 
motifs that might be involved in this reaction. 
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4 Materials 
4.1 Chemicals 
Unless otherwise stated all chemicals were purchased from Merck AG (Darmstadt), 
Carl Roth GmbH (Karlsruhe) or Sigma-Aldrich (Deisenhofen) in the highest available 
purity. Crystallization screens and reagents were ordered from Hampton Research 
(Aliso Viejo, USA), Nextal Biotechnologies (now Qiagen, Hilden) and Jena Bioscience 
(Jena). Radioactive γ32P-ATP was purchased from GE Healthcare. 
4.2 Enzymes, standards, Kits and chromatographic material 
BenchMark Protein Ladder Invitrogen, Karlsruhe 
Calf Intestine Alkaline Phosphatase Fermentas, St. Leon-Rot 
GeneRuler 1kb DNA Ladder Fermentas, St. Leon-Rot 
HiTrap Q HP GE Healthcare, Uppsala Sweden 
Ni-NTA-Agarose Qiagen, Hilden 
NucleoSpin Extract II Macherey-Nagel, Düren 
NucleoSpin Plasmid Quick Pure Macherey-Nagel, Düren 
Platinum Pfx DNA Polymerase Invitrogen, Karlsruhe 
Protein Molecular Weight Marker Fermentas, St. Leon-Rot 
Restriction Endonucleases Fermentas, St. Leon-Rot 
Superdex S200 GE Healthcare, Uppsala Sweden 
Sephacryl S300 GE Healthcare, Uppsala Sweden 
Source 15 S GE Healthcare, Uppsala Sweden 
T4 DNA Ligase Fermentas, St. Leon-Rot 
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Taq DNA Polymerase Fermentas, St. Leon-Rot 
 
Unless otherwise stated all enzymes and kits were used according to the manufactures 
instructions.  
4.3 Oligonucleotides 
SMC for NdeI 5’-GGA AAA AAC ATA TGC CCT ACA TAG AGA AGC 
TTG AAC-3’ 
SMC rev NotI 5’-GAA AAA AGC GGC CGC TTA TCA ATT TCC ATG 
TTC CCA CCC-3’ 
SMC E182 rev 
EcoRI 
5’-GAA GAA TTC TTA TCA TTC CTC TAA AGC TTT 
CTC TTT CTT AG-3’ 
SMC E1006 for 
NcoI 
5’-GAA AAC CAT GGA AAA AGA AAA GAA AAA TGT 
C-3’ 
SMC K39A for 5’-GCT AAT GGA TCT GGA GCG TCT AAC ATT GGA 
GAT GCT ATT CTC-3’ 
SMC K39A rev 5’-GAG AAT AGC ATC TCC AAT GTT AGA CGC TCC 
AGA TCC ATT AGC-3’ 
SMC R59A for 5’-GTT ATC AGC AAA GGC CAT GGC AGC AAG TAG 
AAT CAG TGA TCT CAT ATT TG-3’ 
SMC R59A rev 5’-CAA ATA TGA GAT CAC TGA TTC TAC TTG CTG 
CCA TGG CCT TTG CTG ATA AC-3’ 
SMC Q145A for 5’-GGT TAT AAT ATA GTT CTC GCG GGA GAT ATA 
ACG AAG TTC-3’ 
SMC Q145A rev 5’-GAA CTT CGT TAT ATC TCC CGC GAG AAC TAT 
ATT ATA ACC-3’ 
SMC S1070R for 5’-GAG AAT TGA AGC TAT GAG AGG TGG GGA AAA 
AGC-3’ 
SMC S1070R rev 5’-GCT TTT TCC CCA CCT CTC ATA GCT TCA ATT 
CTC-3’ 
SMC E1098Q for 5’-CAT TTT ATC TCT TCG ATC AGA TAG ATG CTC 
ATT TAG ATG ATG CAA ACG-3’ 
SMC E1098Q 5’-GAG CAT CTA TCT GAT CGA AGA GAT AAA ATG 
GAG CAG G-3’ 
ScpA for NdeI 5’-AAA AAA ACA TAT GGA AAT TGA GGT TAC TCC 
TGT AG-3’ 
ScpA rev NotI 5’-AAA AGC GGC CGC TCA TTA CAT TGG AAC TAC 
TAA GAT CTC G-3’ 
ScpB for NdeI 5’-GGA AAA AAC ATA TGG GAC TAA TAG AGG ATA 
AAG CC-3’ 
ScpB rev NotI 5’-CCT TTT TTG CGG CCG CTT ATC ATT CCT TTT 
TCT TTT CAC TTT CC-3’ 
T7 promotor 5’-TAA TAC GAC TCA CTA TAG GG-3’ 
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T7 terminator 5’-TAT GCT AGT TAT TGC TCA G-3’ 
hol1 for 5’-GGC GAC GTG ATC ACC AGA TGA TGC TAG ATG 
CTT TCC GAA GAG AGA GC-3’ 
hol1 rev 5’-GGC GAC GTG ATC ACC AGA TGA TGC TAG ATG 
CTT TCC GAA GAG AGA GC-3’ 
 
All oligonucleotides were purchased RP-HPLC-purified and lyophilized from Thermo 
Electron Corporation (Ulm). Restriction sites and mutated Codons are underlined. 
4.4 E.coli strains and Plasmids 
E.coli strain genotype Source 
XL1 blue recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac [F´ proAB lacIqZ∆M15 
Tn10 (Tetr)] 
Stratagene, Heidelberg 
Rosetta (DE3) F– ompT hsdSB(rB– mB-) gal dcm (DE3) 
pRARE2 (CamR) 
Novagen, Madison USA 
B834(DE3) F– ompT hsdSB(rB– mB-) met gal dcm 
(DE3) 
Novagen, Madison USA 
 
Plasmid source 
pET21b(+) Novagen, Madison USA 
pET28b(+) Novagen, Madison USA 
pETSH35 (Hoeppner, 2005) 
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5 Methods 
5.1 Cloning 
Genes encoding for full-length Pyrococcus furiosus SMC, ScpA and ScpB proteins 
were amplified by PCR from genomic DNA using SMC for NdeI – SMC rev NotI, 
ScpA for NdeI – ScpA rev NotI and ScpB for NdeI – ScpB rev NotI as primers (see 
4.3). A typical PCR-reaction contained the following components: 
water 35.5 µl
10x Pfx Amplification buffer 5.0 µl
10x PCR Enhancer solution 5.0 µl
50 mM MgSO4 1.0 µl
10 mM dNTP’s 1.5 µl
Template 0.5 µl
Primer forward (50 pmol/µl) 0.5 µl
Primer reverse (50 pmol/µl) 0.5 µl
Pfx DNA Polymerase (2.5 U/µl) 0.5 µl
For amplifying the DNA fragments of interest the following program was used: 
Initial denaturation 94°C 180 s 
Denaturation (30 times) 94°C 30 s 
Annealing (30 times) 50°C 30 s 
Extension (30 times) 68°C 60 s / 1000 kb 
Final extension 68°C 300 s 
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The N- and C-terminal fragments of the SMC protein were amplified using SMC for 
NdeI – SMC E182 rev EcoRI and SMC E1006 for NcoI – SMC rev NotI as primers and 
the cloned full-length SMC gene as a template. 
Mutations were introduced via a 2-step PCR reaction using the wild type gene as a 
template. In the first step the DNA was amplified using SMC for NdeI and the reverse 
mutagenesis Primer and SMC rev NotI and the forward mutagenesis primer resulting in 
two PCR fragments. The two PCR products of the first step were purified by agarose 
gel electrophoreses (see 4.1.2) and 0.5 µl of each fragment were used as template in the 
second PCR reaction. During this overlap PCR in the first three cycles full-length 
template is synthesized without flanking Primers. After adding the amplification 
primers (SMC for NdeI - SMC rev NotI) the DNA fragment is amplified in additional 
30 PCR cycles. 
To analyze and purify the PCR reactions they were mixed with loading dye and DNA 
fragments were separated with an 1% agarose gel at 10 V/cm with 1x TAE as running 
buffer. To visualize DNA with UV light (254 nm) 0.01% (v/v) of a 10 mg/ml ethidium 
bromide solution was added to the gel. Bands of interest were cut out and the DNA was 
extracted with the NucleoSpin Extract II Kit. 
6x loading dye solution: 10 mM Tris-HCl (pH 7.6), 0.03% bromophenol blue, 0.03% 
xylene cyanol FF, 60% (v/v) glycerol, 60 mM EDTA 
50x TAE: 2 M Tris (pH 8.0), 1 M Acetate, 50 mM EDTA 
The extracted PCR products were digested with the appropriate restriction 
endonucleases and purified with the NucleoSpin Extract II Kit. The target vectors were 
digested with the corresponding restriction enzymes, dephosphorylated, purified by 
agarose gel electrophoresis and extracted with the NucleoSpin Extract II Kit. For a 
typical ligation the following components were mixed and incubated over night at 
16°C: 
Water 10 µl
10x ligation buffer 2 µl
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Plasmid 2 µl
Insert 5 µl
T4 DNA Ligase (5 U/µl) 1 µl
Chemical competent E.coli cells were prepared according to Hanahan (Hanahan, 1983). 
200 ml LB media was inoculated with 5 ml over night culture and grown to an OD600 
= 0.35. The cells were cooled down on ice and pelleted by centrifugation (1900 g, 4°C, 
10 min). After resuspension in 30 ml of ice cold TBI buffer and incubation on ice for 
10 min the cells were pelleted again. The pellet was resuspended in 4 ml ice cold TBII, 
aliquoted in 100 µl, flash frozen in liquid nitrogen and stored at -80°C. 
LB media: 1% (w/v) Bacto Trypton, 0.5% (w/v) Yeast Extract, 0.5% (w/v) NaCl, 
adjust pH to 7.0 with 2 N NaOH 
TBI: 100 mM KCl, 50 mM MnCl2, 30 mM potassium acetate, 10 mM CaCl2, 15% (v/v) 
glycerol, adjust pH to 5.8 with 0.2 M Acetate 
TBII: 10 mM MOPS, 10 mM KCl, 75 mM CaCl2, 15% (v/v) glycerol, adjust pH to 7.0 
with NaOH  
For transformation the cells were thawn and either 20 µl of a ligation reaction were 
mixed with XL1blue competent cells or 0.5 µl of a plasmid preparation was mixed with 
Rosetta (DE3) competent cells and incubated on ice for 30 min. After heat shock at 
42°C for 1 min cells were cooled down on ice, 800 µl LB media was added to the cells 
and then incubated for 1 h at 37°C. For selection the cells were spread on LB agar 
plates containing the appropriate antibiotic (1:1000) and incubated over night at 37°C.  
LB Agar: LB media with 1.5% (w/v) agar 
Ampicillin (Na-salt): 100 mg/ml in water 
Kanamycin: 50 mg/ml in water 
Chloramphenicol: 50 mg/ml in 100% ethanol 
Tetraycline: 12.5 mg/ml in 100% ethanol 
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For plasmid isolation 5 ml LB media containing the appropriate antibiotics was 
inoculated with single colonies and incubated over night at 37°C. After pelleting the 
cells plasmids were isolated with the NucleoSpin Plasmid Quick Pure Kit. The 
plasmids were tested for successful insertion of the gene of interest by test PCR with 
Taq DNA polymerase: 
Water 12.5 µl
10x Taq Buffer with (NH4)2SO4 2.0 µl
25 mM MgCl2 2.0 µl
10 mM dNTPs 1.0 µl
Plasmid 0.5 µl
Primer forward (50 pmol/µl) 0.5 µl
Primer reverse (50 pmol/µl) 0.5 µl
Taq DNA Polymerase (1 U/µl) 1.0 µl
The cycling was analogous to the Pfx DNA polymerase PCR except that the extension 
temperature was 72°C and the extension time was calculated for 2000 bp/min. The 
PCR products were analyzed by agarose gel electrophoreses and positive clones were 
sequenced by Medigenomix (Martinsried). Correct plasmids were used to transform 
Rosetta (DE3) cells and after positive expression test clones were stored as glycerol 
cultures (400 µl over night culture + 100 µl 40% (v/v) glycerol). 
5.2 Expression and purification 
All proteins were expressed in Rosetta (DE3) cells growing in LB media. For 
expression 3 l LB media were inoculated with 50 ml of an over night culture and 
protein production was induced by addition of 0.05 mM IPTG at an OD600=0.6. Cells 
were harvested after 3 h of induction, flash frozen in liquid nitrogen and stored at -
80°C. Selenomethionine substituted protein was expressed analogous using methionine 
auxotrophic E.coli B824(DE3) cells growing in LeMaster media (LeMaster and 
Richards, 1985). 
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Cells having expressed SMCcd were resuspended in 20 mM Tris (pH 7.5), 100 mM 
NaCl, 5 mM EDTA and disrupted by sonication. Insoluble proteins and cell debris were 
removed by centrifugation for 20 min at 40000 g. The crude extract was incubated at 
70°C for 10 min to denature endogenous E.coli proteins and subsequently cleared by 
centrifugation (20 min, 40000 g). To remove nucleic acids, proteins were precipitated 
by addition of ammonium sulfate to the supernatant to 80% of saturation. After 1 h 
incubation at 4°C precipitated proteins were pelleted by centrifugation (10 min, 20000 
g) and dissolved in buffer A. The protein solution was separated on a Sephacryl S300 
26/60 size exclusion column with buffer B. SMCcd containing fractions were pooled 
and dialyzed over night against 50 volumes 20 mM Tris (pH 8.0), 1 mM EDTA. The 
dialyzed protein was loaded on a HiTrap Q HP ion exchange column and eluted with a 
linear gradient over 10 column volumes (cv) from 100% buffer A to 100% buffer B. 
For further purification the flow-through and SMCcd containing fractions were pooled, 
loaded on a Source 15 S ion exchange column and eluted with a linear gradient from 
100% buffer A to 100% buffer B over 20 cv. Protein containing fractions were pooled, 
concentrated and finally purified by Superdex S200 16/60 size exclusion 
chromatography in buffer C. Selenomethione substituted protein was purified 
analogous with addition of 1 mM DTT to all buffers. 
Buffer A: 20 mM Tris (pH 8.0), 100 mM NaCl, 1 mM EDTA 
Buffer B: 20 mM Tris (pH 8.0), 1 M NaCl, 1 mM EDTA 
Buffer C: 5 mM Tris (pH 8.0), 100 mM NaCl, 0.1 mM EDTA 
ScpA containing cells were resuspended in Ni-NTA-A and disrupted by sonication. 
After centrifugation (20 min, 40000g) the supernatant was loaded on a Ni-NTA gravity 
flow IMAC column. The column was washed with 10 cv Ni-NTA-W, 5 cv Ni-NTA-A 
and the protein was eluted with 100% Ni-NTA-B. ScpA containing fractions were 
pooled and dialyzed over night against 50 volumes 20 mM MES (pH 6.0), 50 mM 
NaCl, 1 mM EDTA. The protein was loaded on a HiTrap Q HP IEX column and eluted 
with a linear gradient from 50 mM NaCl to 1 M NaCl in 20 mM MES (pH 6.0), 1 mM 
EDTA. As a final purification step the protein was concentrated and loaded on a 
Superdex S200 16/60 size exclusion column with buffer C as running buffer. For 
complex formation the N-terminal His-tag was cleaved with Thrombin, uncleaved 
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protein separated by Ni-NTA IMAC and ScpA without His-tag mixed 1:1 with SMCcd 
protein. After incubation for 30 min on ice formed complexes were separated from free 
protein via size exclusion chromatography with buffer C. 
Ni-NTA-A: 50 mM NaH2PO4 (pH 8),300 mM NaCl, 10 mM Imidazol 
Ni-NTA-B: 50 mM NaH2PO4 (pH 8),300 mM NaCl, 250 mM Imidazol 
Ni-NTA-W: 50 mM NaH2PO4 (pH 8),1 M NaCl, 10 mM Imidazol 
For purification of ScpB cells were resuspended in Ni-NTA-A and disrupted by 
sonication. The crude extract was cleared by centrifugation (20 min, 40000g) and 
purified by Ni-NTA IMAC according to ScpA. ScpB containing fractions were pooled, 
concentrated and diluted with water to 50 mM NaCl before being loaded on a HiTrap Q 
HP IEX column. After elution the ScpB containing fraction were pooled, concentrated 
and the protein further purified by size exclusion chromatography (Superdex S200) 
with 5 mM Tris (pH 8.5), 300 mM NaCl, 0.1 mM EDTA as buffer. 
Protein samples were analyzed by discontinuous SDS-PAGE (Laemmli, 1970). After 
mixing with Laemmli buffer the samples were denatured for 5 min at 95°C, separated 
in a 15% gel (4% stacking gel) with 1x TGS as running buffer at 30 V/cm and stained 
with Coomassie. 
4x lower buffer: 3 M Tris (pH 8.5), 0.4% (w/v) SDS 
4x upper buffer: 0.5 M Tris (pH 6.8), 0.4% (w/v) SDS 
4x Laemmli buffer: 0.11 M Tris (pH 6.8), 16% (v/v), 4% (w/v) SDS, 5% (v/v) β-
mercaptoethanol, 0.05% (w/v) bromophenol blue 
10x TGS buffer: 0.5 M Tris (pH 8.3), 1.9 M glycin, 1% (w/v) SDS 
Coomassie stain: 50% (v/v) ethanol, 7% (v/v) acetic acid, 0.2% (w/v) Coomassie 
Brilliant Blue R250 
Proteins were concentrated by centrifugation (850 g, 4°C) using Amicon Ultra-15 
Centrifugal Filter Units (Millipore, Billerica, USA). Concentrations of the protein 
solutions were determined by UV absorption at 280 nm and the corresponding 
extinction coefficient obtained by primary sequence analysis at www.expasy.ch. 
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5.3 Analytical size exclusion chromatography 
ATP-dependent dimerization of SMCcd wt and E1098Q was tested by analytical size 
exclusion chromatography with 20 mM Tris (pH 8.0), 100 mM NaCl, 5 mM MgCl2, ± 
0.5 mM ATP as running buffer. For interaction studies the retention volume of the 
proteins was determined alone and after mixing with ATP or ScpA and incubation in 
buffer C. Each time 50 µl of the protein solution was loaded on a Superdex S200 
10/300 column at a flow rate of 0.5 ml/min. 
5.4 ATPase activity assay 
To test the ATPase activity 10 µM protein was incubated with and without 25 µM 
dsDNA (annealed hol1 for and hol1 rev) in 50 mM Tris (pH 7.5), 100 mM NaCl, 10 
mM MgCl2 and 1 mM ATP (containing 500 fold diluted γ32P-ATP) at 55°C for 10 min. 
Aliquots of 1 µl were spotted on a PEI Cellulose F thin-layer chromatography plate 
(Merck, Darmstadt) and developed in 0.5 M LiCl, 1 M formic acid. After drying 
radioactive signals were recorded with a storage phosphor screen (GE Healthcare, 
Uppsala) and read out with a Storm imaging system (GE Healthcare, Uppsala). Data 
were processed with ImageQuant Software (GE Healthcare, Uppsala). The ability of 
ADP, ADP-AlF4- and ADP-BeF3- to inhibit these reactions was tested by addition of 5 
mM of the inhibitors to the reaction described above (for preparation of the inhibitors 
see 5.7). 
5.5 ATP binding assay 
The ATP binding capability of the proteins was assayed by nitrocellulose filter binding 
assay. 2 µM protein was incubated in 50 mM Tris (pH 7.5), 100 mM NaCl, 10 mM 
MgCl2 and 25 µM ATP (containing 500 fold diluted γ32P-ATP) for 5 min on ice. The 
mixtures were applied on a nitrocellulose membrane with a dot blot device (Whatman, 
Brentford, UK). A storage phosphor screen was exposed to the dried membrane and 
read out with a Storm imaging system. Data were processed with ImageQuant 
Software. 
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5.6 Reverse adenylate kinase activity assay 
1 µM protein was incubated with 1 mM ADP in 50 mM Tris (pH 7.5), 100 mM NaCl 
and 10 mM MgCl2 at 55°C for 2 hours. Wild type protein was assayed with and without 
addition of 2.5 mM AP5A (Sigma-Aldrich, Taufkirchen, Germany). To determine the 
amount of produced ATP, 100 µl of the reaction mixture were mixed with 100 µl of the 
“ATP determination kit” reagent from Biaffin (Kassel). The ATP generated in the 
reverse adenylate kinase reaction was used by firefly luciferase to oxidize D-luciferin. 
The resulting chemiluminescence was recorded and integrated over 10 s with a Lumat 
LB 9507 luminometer (Berthold Technologies, Bad Wildbad) immediately after 
mixing. 
5.7 Crystallization 
Initial screening for crystallization conditions was performed in CrystalEX 96 well 
sitting drop plates (Corning, New York, USA) using commercially available sparse 
matrix screens from Hampton, Jena Bioscience and Nextal. Setups were pipeted either 
by hand mixing of 1 µl protein solution with 1 µl crystallization buffer or by a Hydra II 
semi-automatic protein crystallization robot (0.2 µl + 0.2 µl) (Matrix Technologies 
Corporation, Hudson, USA). To improve crystal quality the conditions of initial hits 
were refined by varying the protein concentration, concentrations of the components of 
the crystallization buffer, pH, temperature, drop size, mixing ratio of the drop and ratio 
between drop and reservoir volume. Refinements were set up in 24 well format either 
in sitting drop Cryschem plates (Hampton Research, Aliso Viejo, USA) or hanging 
drop EasyXtal Tool plates (Nextal Biotechnologies - now Qiagen, Hilden). 
SMCcd was crystallized by hanging-drop vapor diffusion method by mixing 2 µl 
protein solution (8 mg/ml in buffer C) with 2 µl precipitant solution (16% (w/v) 
PEG800, 15% (v/v) glycerol and 0.5 M KCl). Crystals appeared at 25°C within a few 
days and were directly flash frozen in liquid nitrogen. 
Crystals of SMCcdE1098Q-ATP were obtained by mixing 2 µl protein solution (5 
mg/ml in buffer C supplemented with 5 mM ATP and 20 mM MgCl2) with 2 µl 
precipitant solution (0.1 M Na-acetate [pH 4.6], 6% (w/v) PEG400 and 12% (v/v) 
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ethanol) at 25°C using the hanging-drop vapor diffusion method. As a cryoprotectant 
30% (v/v) (±)-2-methyl-2,4-pentandiole was added to the precipitant solution. After a 
few seconds of incubation in this solution the crystals were flash frozen in liquid 
nitrogen. 
SMCcd-ADP-AlF4- and SMCcd-ADP-BeF3- were crystallized as described for 
SMCcdE1098Q-ATP. The buffers were identical except that ATP was replaced by 
either 5 mM ADP, 5 mM AlCl3, 20 mM NaF or 5 mM ADP, 5 mM BeCl2, 20 mM 
NaF. 
SMCcd-AP5A (9 mg/ml in buffer C with 2.5 mM AP5A, 25 mM MgCl2 ) was 
crystallized by sitting-drop vapor diffusion at 25°C after mixing 2 µl protein solution 
with 2 µl precipitant solution (BisTris [pH 6.6], 16% (w/v) PEG3350). Crystals were 
flash frozen in liquid nitrogen after the addition of 30% (w/v) PEG400. 
5.8 Data collection and processing 
Diffraction data were recorded at ESRF (European Synchrotron Radiation Facility – 
Grenoble, France) and SLS (Swiss Light Source - Villigen, Switzerland) synchrotron 
radiation sources. Optimal starting angle, total oscillation range and rotation angle per 
frame were determined using the “Strategy” option in MOSFLM. MAD and SAD 
datasets were recorded from selenomethionine substituted protein crystals starting with 
the peak wavelength. Best wavelengths for the peak, inflection and high remote data 
sets were determined by fluorescence scan on each crystal (for details see results). 
Data of SMCcd, SMCcdE1089Q-ATP, SMCcd-ADP-AlF and SMCcd-ADP-BeF were 
indexed and integrated using DENZO (Otwinowski, 1997). Scaling was performed 
with SCALEPACK. The SMCcd-AP5A Data were processed using XDS (Kabsch, 
1993). 
5.9 Structure solution and refinement 
The structure of the SMCcd protein was solved by MAD phasing. 10 of 11 possible 
anomalous scatterers were located with Shake’n’Bake (Weeks and Miller, 1999). With 
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this information SHARP (Bricogne et al., 2003) calculated the phases which were 
improved by SOLOMON (CCP4, 1994). An initial model was autobuilt in the resulting 
electron density with repeated cycles of RESOLVE and REFMAC. After bulk solvent 
and overall anisotropic B-factor correction the model was completed and refined by 
repeated cycles of manual model building with MAIN (Turck, 1992) and positional 
minimization and B-factor refinement with CNS (Brunger et al., 1998). Waters were 
automatically built with ARP/WARP (Morris et al., 2003). 
The phases of the SMCcdE1098Q-ATP structure were obtained according to the apo 
protein using only the peak wavelength. The model of the SMCcd protein was 
manually positioned in the experimental density and refined as described above. 
The structures of SMCcd-ADP-AlF4- and SMCcd-ADP-BeF3- were solved by 
molecular replacement using MOLREP (CNS) and SMCcd-ATP as search model. 
Refinement of the structures was performed as described above. Solvent molecules 
were positioned by WATERPICK a part of CNS. 
The phases for the SMCcd-AP5A complex were obtained by molecular replacement 
with PHASER (CCP4, 1994) using SMCcdE1098Q-ATP lacking the residues 1155-
1169 as a search model. Model refinement was performed by repeated cycles of manual 
model building in COOT (Emsley and Cowtan, 2004) and positional minimization, 
occupancy (only waters and COOH-groups) and B-factor refinement with CNS. Water 
molecules were built by WATERPICK (CNS). 
CNS refinement was performed with the maximum likelihood method using amplitudes 
as refinement target and taking the Engh & Huber parameters into account (Engh, 
1991). The quality of the refinement was monitored by calculating the Rwork and Rfree of 
the model. The Rfree was calculated for 5% of the reflection omitted from the 
refinement. The geometry of the refined model was checked with the program 
PROCHECK (CCP4, 1994). (for details see results)  
All pdb, topology and parameter files for the heterocompounds were downloaded from 
the HicUp database (Kleywegt and Jones, 1998). 
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6 Results 
6.1 Cloning and expression 
6.1.1 Pyrococcus furiosus SMC 
Database search for a homologue of SMC proteins in Pyrococcus furiosus yielded one 
single hit (www.expasy.org). The protein with the locus name pf1843 and the primary 
accession number Q8TZY2 has high sequence homology to SMC proteins from other 
archaea, bacteria yeast and human especially in the N- and C-terminal region 
containing the ABC-ATPase motifs (see appendix Fig. 42). Interestingly the deposited 
sequence shows an N-terminal extension not found in other SMC proteins except yeast 
SMC4. After cloning this gene into a pET21 vector no expression could be observed. 
Cloning a truncated version of this gene lacking the above mentioned extension a 
protein of the appropriate size (~135 kDa) was expressed (Fig.12 A). 
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Figure 12: Expression and purification of full-length SMC. 
A) M: MW-marker; 1: total cell lysate before induction; 2: total cell lysate 3 h after induction. B) 
M: BenchMark protein ladder; 1+2: elution fraction from final size exclusion column 
 
The cells were grown at 37°C and soluble SMC protein was expressed after 3 h of 
induction. After disrupting the cells by sonication the protein could be purified with a 
heat step, ammonium sulfate precipitation, high salt size exclusion and anion exchange 
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chromatography according to SMCcd. In contrast to SMCcd the full-length protein 
does not bind to the cation exchang resin Source S and therefore after the final size 
exclusion chromatography contaminating proteins remained in the protein sample (Fig. 
12 B). The protein was not further purified, because its long and flexible coiled-coil 
domain makes it not suitable for crystallization. To obtain a more globular protein for 
crystallization, constructs consisting only of the terminal head domain and a short part 
of the coiled-coil of different length were cloned. The lengths of the proteins were 
designed after analyzing the sequence of Pfu SMC for predicted coiled-coil regions 
with the COILS program (http://www.ch.embnet.org/software/COILS_form.html). 
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Figure 13: Coiled-coil prediction for the full-length Pfu SMC protein 
Coiled-coil probability for the full-length Pfu SMC protein calculated with COILS. In green 
calculated with a window of 14 residues (green), in blue 21 and in red 28 residues. The red 
triangles mark the ends of the 2 peptide chains of SMCcd. Triangles in dark and light grey 
highlight 2 more constructs that were not used in this thesis. 
 
The plot shows three regions with low coiled-coil probability: the N- and C-terminal 
end of the protein forming the ABC-ATPase domain and in the middle the hinge 
domain. With this theoretical information three different constructs were designed that 
comprise the N- and C-terminal part up to the beginning of the coiled-coil plus 
additional 20, 40 and 60 residues. The DNA fragments were cloned into the pETSH35 
vector. This vector is derived from pET21 and allows a bicistronic expression of two 
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proteins. In the case of SMCcd the N- terminal residues 1 – 182 and C-terminal 
residues 1006 – 1177 were cloned with NdeI/EcoRI and NcoI/NotI into the vector to 
express the ABC-ATPase domain of Pfu SMC without additional amino acids from a 
tag or linker (Fig. 14 A). 
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Figure 14: Expression and purification of SMCcd 
A) Cloning strategy for the bicistronic expression of the two peptide chains (1-182 / 1006-1177) 
of SMCcd. In blue the two ribosome binding sites, in green the 2 5’ and in red the 2 3’ restriction 
sites. B) Expression test of SMCcd analyzed in a 15% SDS gel. Arrows N and C mark the N- and 
C-terminal fragment. M: MW-Marker; 1: total cell lysate before induction; 2: total cell lysate 3 h 
after induction. C) Typical elution profile for SMCcd on a S200 16/60 column. Blue line: 
absorbance at 280 nm; red line: absorbance at 260 nm. D) Purified wt SMCcd. M: MW-Marker; 
1: purified SMCcd 
 
E.coli Rosetta (DE3) cells transformed with the resulting plasmid strongly expressed 
the two peptide chains in an approximately 1:1 stoichiometry after induction with IPTG 
(Fig. 14 B). The two fragments are soluble and heat stable indicating that they fold to 
their native conformation. This feature was used for the first purification step, after cell 
disruption by sonication E.coli proteins were denatured at 70°C and separated by 
centrifugation. In a next step proteins were precipitated with ammoniumsulfat, 
resuspended and separated by size exclusion chromatography with a high salt running 
buffer to remove of remaining nucleic acids and nucleotides. After reducing the salt 
concentration by dialysis the protein was further purified using an anion exchange 
chromatography. At pH 8 the vast majority of SMCcd does not bind the material 
indicating again that the two chains bind together and have an actual pI close to the 
theoretical 8.4 of a single chain protein with identical sequence. The C-terminal part 
alone has a theoretical pI of 6.77 and therefore should bind to the column, only the N-
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terminal part with a pI of 8.67 should be in the flow through (calculated with 
ProtParam / www.expasy.ch). For further purification the protein was bound to a cation 
exchanger, eluted and concentrated. The final purification step was performed by size 
exclusion chromatography. SMCcd eluted as a single peak at a retention volume 
corresponding to a single protein consisting of both peptide chains (Fig. 14 C). The 
elution profile and the analysis via SDS-Page (Fig. 14 D) show clearly that the 
bicistronic expression of the N- and C-terminal part of Pfu SMC bind in a 1:1 
stoichiometry to each other, forming a protein that could be purified to homogeneity. 
6.1.2 Pyrococcus furiosus ScpA 
Database search for a Pyrococcus furiosus homologue of the bacterial ScpA protein 
resulted in one single hit. In the Pfu genome the gene for the protein with the ordered 
locus name pf1842 and the primary accession number Q8TZY3 overlaps with the gene 
for the SMC protein indicating a close relation between the two proteins 
(http://www.ncbi.nlm.nih.gov). The gene encoding Pfu ScpA was cloned into a pET28 
vector using NdeI/NotI restriction sites to fuse an N-terminal 6xHis-tag to the protein. 
The fusion protein could be expressed in Rosetta (DE3) cells at 37°C for 3 h (Fig. 15 
A) and was in the soluble fraction. Unlike SMCcd it is not heat stable and therefore the 
crude extract was loaded directly onto a Ni-NTA column.  
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Figure 15: Expression and purification of His-ScpA 
A) Expression test of His-ScpA. M: MW-Marker; 1: total cell lysate before induction; 2: total cell 
lysate 3 h after induction. B) Typical elution profile for His-ScpA on a S200 16/60 column. Blue 
line: absorbance at 280 nm; red line: absorbance at 260 nm. C) Elution fractions from S200 size 
exclusion column containing purified His-ScpA. M: MW-Marker; 1-5: elution fractions. 
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The eluted protein was dialyzed against low salt buffer, further purified by an ion 
exchange chromatography and finally polished on a S200 size exclusion column. His-
ScpA eluted as a single peak (Fig. 15 B) and showed a high degree of purity on a 
Coomassie stained acrylamid gel (Fig. 15 C). For crystallization and complex 
formation with SMCcd the His-tag was cleaved from the protein using a thrombin 
cleavage site between the tag and the protein. As shown in figure 16 B thrombin 
cleaves of the tag from His-ScpA (lane 1) resulting in a smaller protein without tag 
(lane 3). To obtain a homogenous protein species uncleaved protein was removed by a 
second Ni-NTA column. After the incubation of cleaved ScpA with SMCcd a complex 
containing one molecule ScpA and one molecule SMCcd could be eluted from a S200 
size exclusion column (Fig. 16 B and C) 
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Figure 16: Thrombin cleavage of His-ScpA and complex formation with SMCcd 
A) Analyses of the proteolytic removal of the His-tag from ScpA. M: MW-Marker; 1: His-ScpA 
before cleavage; 2: mixture of uncleaved and cleaved protein; 3: cleaved ScpA without His-tag. 
B) Elution profile of SMCcd-ScpA complex on a S200 size exclusion column. Blue line: 
absorbance at 280 nm; red line: absorbance at 260 nm. C) SMCcd-ScpA complex eluted from 
S200 column. Arrows indicating the 2 proteins (N and C indicating the two fragments of SMCcd) 
M: MW-Marker; 1: SMCcd-ScpA complex. 
 
6.1.3 Pyrococcus furiosus ScpB 
Database search for a possible ScpB homologue in Pyrococcus furious resulted in a 
protein with the ordered locus name pf2021 and the primary accession number 
Q8TZH3. The gene was cloned into pET28 to fuse a C-terminal 6x His-tag for 
purification. Expression in Rosetta (DE3) cells resulted in soluble overexpressed 
protein with the expected size. His-ScpB could be purified by IMAC, IEX and size 
exclusion chromatography. 
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Figure 17: Expression and purification of His-ScpB 
A) Expression test of His-ScpB. M: MW-Marker; 1: total cell lysate before induction; 2: total cell 
lysate 3 h after induction. B) Typical elution profile for His-ScpB on a S200 26/60 column. Blue 
line: absorbance at 280 nm; red line: absorbance at 260 nm. C) Elution fractions from S200 size 
exclusion column containing purified His-ScpB. M: MW-Marker; 1-3: elution fractions. 
 
6.2 Biochemical studies 
6.2.1 Analytical size exclusion chromatography 
SMCcd although consisting of two peptide chains and being only a part of the Pfu SMC 
protein could be purified as a soluble protein. The Stoke’s radius of SMCcd determined 
by analytical size exclusion chromatography corresponds to a protein with a molecular 
weight of roughly 40 kDa which coincides with a globular and monomeric protein (Fig. 
18). This indicates that the designed SMCcd resembles the globular ABC ATPase 
domain and could be used to study the biochemical and structural features of the 
catalytic domain of the full-length protein. 
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Figure 18: Size exclusion profiles of SMCcd 
SMCcd analyzed on a S200 10/300 size exclusion column with indicated molecular weight 
standards. SMCcd elutes in a monomeric peak (blue line). Addition of slowly hydrolysable ATP 
analogue ATPγS leads to formation of dimers (orange line). The fraction of dimeric protein could 
be increased using ATP in the buffer and the active site mutant SMCcd-E1098Q (red line). 
 
Presence of ATP leads to engagement of two ATP ABC-ATPase domains. To test if 
this is also true for SMCcd, wild type protein was analyzed on a size exclusion column 
in the presence of 0.5 mM ATP in the running buffer. Probably due to ATP hydrolysis 
no dimerization was observed in this experiment. To overcome the problem with ATP 
hydrolysis one can use slowly hydrolizable ATP analogues such as ATPγS to study the 
effect of ATP. Preincubation of SMCcd with ATPγS lead to formation of a protein 
species with a Stoke’s radius corresponding to a dimer (Fig. 18 orange line). The 
fraction of dimeric protein could be increased using a Walker B motif mutant of 
SMCcd (Fig. 18 red line). Mutating the active site glutamic acid 1098 to glutamine 
reduces the ATPase activity (Fig. 20) and traps the protein in the ATP bound state 
thereby stabilizing the dimer. 
Monitoring the retention volume can also be used to verify interaction between 
proteins. If two or more proteins stably interact they stay together during a size 
exclusion chromatography and elute according to the size of the complex. To test for 
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the physical interaction SMCcd, ScpA and ScpB were analyzed alone, two of them and 
all three together on a S200 10/300 size exclusion column. All three proteins alone 
elute as monomers from the column. ScpB shows in this experiment interactions with 
neither SMCcd nor ScpA. SMCcd and ScpA form a stable complex that could be 
separated from residual monomeric protein. The complex consists of one SMCcd and 
one ScpA protein as determined by the retention volume (Fig. 19). 
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Figure 19: Size exclusion profiles of SMCcd and ScpA 
Stoke’s radius determined on a S200 10/300 size exclusion column with indicated molecular 
weight standards. In blue the monomeric peak of SMCcd alone. The green line shows the elution 
profile of ScpA. After preincubation of the two proteins they form a stable 1:1 complex (red line). 
 
6.2.2 ATPase activity assay 
SMCcd comprises the ABC-ATPase domain of Pyrococcus furiosus SMC protein. To 
test if this domain on its own is an active enzyme the ATPase activity of SMCcd was 
assayed using radioactive γ32P-ATP as substrate. The reaction products were separated 
with thin layer chromatography (Fig. 20 A). Signal from the radioactive phosphate was 
detected and quantified. All reactions were incubated at 55°C because the source 
organism Pyrococcus furiosus is thermophilic and grows at temperatures around 
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100°C. Decreasing the temperature to 25°C reduces the reaction rate to 50% but does 
not completely abolish it (Fig. 20 B). 
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Figure 20: ATPase activity assay of wt and mutant SMCcd 
A) Exemplary result from a thin layer chromatography analysis of an ATPase reaction. The upper 
spots correspond to the free radioactive γ phosphate. ATP migrates very slowly and remains close 
to the spotted point at the bottom. B) Relative ATPase activity of SMCcd assayed at 25°C and 
55°C. C) ATPase activity in absence (white) and presence (black) of DNA. Insert: relative 
stimulation of the ATPase activity of SMCcd (white) and SMCcd:ScpA (black). Error bars 
represent the standard deviation of three experiments. 
 
To clarify the mechanism of ATP hydrolysis by SMCcd wild type and mutant protein 
was assayed for ATPase activity. The basal turn over rate of wild type SMCcd was 
determined to 1 ± 0.18 ATP/min. Mutating arginine 59 to an alanine does not change 
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the basal activity of SMCcd (Fig. 20 C). All other three mutations strongly reduce the 
basal ATPase activity of SMCcd. Replacing the water activating glutamic acid in the 
Walker B motif by a glutamine reduces the activity of SMCcd. The K39A mutation in 
the Walker A motif interferes with ATP binding (see 6.2.3) and strongly decreases the 
activity almost to zero. Also the signature motif mutant S1070R nearly completely 
abolishes the hydrolysis of ATP by SMCcd. 
To test whether DNA can activate SMCcd, the ATPase activity was determined in the 
presence of DNA. Addition of a 42mer dsDNA to the reaction of the wild type protein 
strongly increases the activity to 14 ± 0.9 ATP/min. In the Walker B mutant the 
addition of DNA slightly increases the activity but it is still lower than the wild type 
basal activity. Mutation of arginine 59 to alanine completely abolishes the DNA 
stimulation of the ATPase activity. The presence of DNA does not lead to an increased 
activity of the K39A and S1070R mutant. 
ScpA and ScpB do not have any intrinsic ATPase activity. Addition of ScpA which 
interacts with SMCcd (see 6.2.1) to the ATPase reaction has no influence on the basal 
activity and only leads to a weak reduction of the DNA stimulated activity (Fig. 20 C 
insert). 
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Figure 21: ATPase activity of SMCcd in prescence of inhibitors. 
The ATPase activity of 10 µM wt SMCcd was assayed in the presence of 1 mM ATP and 5 mM 
ADP, ADP-AlF4- or ADP-BeF3-. Relative activity compared to the uninhibited reaction is shown 
in columns. 
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ADP as product of the ATPase reaction and ADP-AlF4- and ADP-BeF3- as transition 
state analogues of the ATP hydrolysis by ATPases are potent inhibitors of the reaction 
of ABC-ATPases. To test the ability of all three to inhibit the ATPase reaction of wt 
SMCcd the activity was assayed in the presence of 5 mM ADP, ADP-AlF4- and ADP-
BeF3-. ADP as a product reduces under this reaction conditions the amount of 
hydrolyzed ATP to 1/3 of the uninhibited reaction (Fig. 21). The addition of either 
ADP-AlF4- or ADP-BeF3- to the reaction mixture and thereby formation of a complex 
analogues to the transition state of the hydrolysis raction nearly completely abolishes 
the ATPase activity of wt SMCcd (Fig. 21). 
6.2.3 ATP binding assay 
To analyze if the differences in the ATPase activity are associated with defects in ATP 
binding rather than ATP hydrolysis the ATP binding properties of wild type and mutant 
SMCcd were determined. The proteins were incubated with radioactive γ32P-ATP on 
ice to allow binding but reduce ATP hydrolysis.  
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Figure 22: ATP binding assays of wild type and mutant SMCcd. 
A) Typical result of a nitrocellulose filter binding assay to determine ATP binding capability of 
SMCcd. B: background; wt: wild type; K39A, R59A, E1098Q, S1070R: mutant SMCcd. B) ATP 
binding capacity of wt and mutant SMCcd assayed in triplicate. 
 
While sucking the reaction mixture through a nitrocellulose membrane proteins bind to 
the membrane and retain bound ATP that could be detected, unbound ATP does not 
bind to the membrane and is in the flow through. Comparing the retention of wild type 
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and mutant SMCcd proteins shows that only the Walker A mutant K39A is deficient in 
ATP binding and all other proteins show virtual identical ATP binding (Fig. 22). 
6.2.4 Reverse adenylate kinase activity 
The ability of SMCcd to catalyze the reverse adenylate kinase reaction was assayed by 
incubating SMCcd with ADP. The developed ATP was used by firefly luciferase to 
oxidize D-luciferin and the resulting luminescence was used to quantify the amount of 
ATP. 
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Figure 23: Reverse adenylate kinase activity of SMCcd. 
The amount of produced ATP was quantified by integrating the generated luminescence signal 
from luciferase. In grey the activity with 200 µM ADP and in black with 1 mM ADP in the 
reaction mixture are depicted. wt: wild type protein; K39A, Q145A, S1070R mutant SMCcd; 
wt+AP5A: wild type protein with 2.5 mM AP5A inhibitor added to the reaction. 
 
At a concentration of 200 µM the activity of all 3 mutant proteins is decreased 10 – 
20% to that of wild type activity (Fig. 23). This background activity probably comes 
from residual impurities by E.coli adenylate kinases. Adding the inhibitor AP5A to the 
wild type reaction abolishes the activity nearly completely. Providing 1 mM ADP in 
the reaction mixture increases the amount of produced ATP from the Q145A mutant to 
50% compared to the wild type reaction. Both other mutants have almost the same 
relative activity compared to reactions with lower ADP concentration. The addition of 
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inhibitor to the wild type reaction reduces the relative activity at 1 mM ADP 
concentration to the same level as in the 200 mM reaction. 
6.3 Crystallization, structure solution and refinement 
6.3.1 Apo wild type SMCcd 
The prerequisite to determine the structure of a protein to atomic resolution using X-ray 
crystallography is growing crystals of the protein. For crystallization trials the purified 
wild type SMCcd was concentrated to 8 mg/ml in 5 mM Tris (pH 8.0), 100 mM NaCl 
and 0.1 mM EDTA. Screening was performed mixing 1 µl protein solution with 1 µl 
precipitant solution from commercially available sparse matrix screens at 25°C. After 
one to two days crystals were grown in several different precipitant solutions. Most 
promising with four single three dimensional crystals was the condition A2 of the Jena 
Bioscience screen 5 (12% (w/v) PEG8000, 10% (v/v) glycerol, 0.5 M KCl). This initial 
hit was refined to 16 % (w/v) PEG 8000, 15 % (v/v) glycerol, 0.5 M KCl. To avoid 
radiation damage during data collection at synchrotron X-ray sources the protein 
crystals are kept at 100 K, therefore and for storage the crystals were flash frozen 
without further cryo protocol. 15% (v/v) glycerol in the crystallization condition was 
enough to avoid formation of ice crystals. Crystals of SMCcd diffracted to a limiting 
resolution of 2.0 Å at beamline ID29 (ESRF). Data were recorded using an ADSC 
Q210 2D detector. Indexing with DENZO determined the unit cell to a = 102.3 Å b = 
56.7 Å c = 78.9 Å α = 90° β = 123.0° γ = 90° with a C2 symmetry. For further details 
of data collection see appendix table 2. 
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Figure 24: Images of the structure solution steps of SMCcd apo form. 
A) Crystals of SMCcd. B) Diffraction pattern of SMCcd. C) 7 of the 8 Selenium sites found by 
Shake’n’Bake in blue spheres with anomalous difference electron density map contoured at 4σ as 
red mesh. D) MAD and 2Fo-Fc electron densities contoured at 1σ around a portion of the refined 
model (color-coded sticks). 
 
To be able to perform a MAD experiment for phasing the protein was additionally 
expressed in a methionine auxotroph E.coli strain in selenomethionine containing 
media. Selenomethionine substituted protein behaved as the wild type protein during 
expression, purification and crystallization. Anomalous data were recorded at 100 K 
with a marCCD detector at the PX beamline of the SLS. The exact wavelength of the 
peak, inflection and high remote dataset for the MAD experiment were determined by a 
fluorescence scan (for details see appendix table 1). All three datasets were recorded at 
one single crystal to a limiting resolution of 2.5 Å. Data were indexed, integrated and 
scaled with DENZO and SCALEPACK (for details see appendix table 2). 
The number of molecules per asymmetric unit was determined by calculating the 
Mathews coefficient with the unit cell parameters, the symmetry and the molecular 
weight of SMCcd. The calculated Matthews coefficient is 2.4 for one molecule per 
asymmetric unit with a solvent content of roughly 50%. Taking this into account one 
Results 51 
 
 
 
asymmetric unit should contain eleven methionines and therefore in the case of the 
selenomethionine substituted protein eleven anomalous scatterers. Eight out the eleven 
anomalous scatterer were located with the help of Shake’n’Bake using the three 
datasets of the MAD experiment. With these sites the phases were calculated with 
SHARP and improved using density modification tools of SOLOMON. The initial 
model built into the resulting density by RESOLVE and REFMAC was completed with 
repeated cycles of manual model building in MAIN and refinement with CNS. The 
final model contains residues 1-56, 77-167, 1012-1145 and 1148-1173 and in total 
2748 non hydrogen atoms and 205 solvent molecules and was refined to a final R factor 
of 20.7 (Rfree 26.1). For further details of the refined model see appendix table 2. 
6.3.2 ATP bound E1098Q SMCcd 
Wild type SMCcd could not be crystallized in complex with ATP, AMPPNP or ATPγS 
As in the biochemical assays E1098Q SMCcd behaved identical to the wild type 
protein except the decreased ATPase activity this mutant was used to determine the 
structure of the ATP bound dimerized form of SMCcd. After concentrating the purified 
E1098Q SMCcd to 10 mg/ml (in 5 mM Tris (pH 8.0), 100 mM NaCl. 0.1 mM EDTA) 
it was mixed 1:1 with 10 mM ATP, 40 mM MgCl2 in the same buffer and incubated on 
ice allowing binding and dimerization. Initial screening resulted in some hits that could 
be refined to optimal precipitation solution containing 0.1 M sodium acetate (pH 4.6), 
6% (w/v) PEG400 and 12% ethanol. Crystals grew over night but dissolved after a 
couple of days perhaps due to residual ATP hydrolysis activity of the E1098Q mutant. 
Crystals were cryoprotected by adding 30% (v/v) MPD to the precipitation solution and 
flash frozen in liquid nitrogen. To obtain experimental phases selenomethionine 
substituted protein was used to collect a data set at the peak wavelength determined by 
a fluorescence scan at beamline PX (SLS). The data with a limiting resolution of 2.8 Å 
were indexed, integrated and scaled with the HKL suite. ATP bound E1098Q SMCcd 
crystallized in space group P3121 with the unit cell parameters a = 102.6 Å, b = 102.6 
Å, c = 87.2 Å, α = 90°, β = 90°, γ = 120° and one molecule per asymmetric unit 
(Matthews coefficient 3.31 and 63% solvent). SnB was able to locate eight selenium 
sites and with these coordinates phases were obtained analogously to the apo form. 
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After positioning the nucleotide free model into the density clear Fo-Fc density for the 
bound ATP and a Magnesium ion appeared. ATPand the ion were placed in the density 
and refined together with the protein. The structure was refined as described above to a 
final R-factor of 21.0 (Rfree 26.9) and comprises residues 2-167, 1009-1172, one ATP 
molecule, one Mg2+ ion and 205 solvent molecules. For refinement statistics see 
appendix table 2. 
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Figure 25: Crystals, diffraction and density images of ATP bound E1098Q SMCcd. 
A) Crystals of ATP bound E1098Q SMCcd. B) Diffraction pattern of ATP bound E1098Q 
SMCcd. C) SAD and 2Fo-Fc electron densities contoured at 1σ around the ATP moiety 
superimposed with the refined model (color-coded sticks, magenta sphere: Mg2+). 
 
6.3.3 ADP-AlF4- and ADP-BeF3- bound to SMCcd 
To trap an ATPase in the transition state of the hydrolytic reaction one can use ADP 
together with orthovanadate (VO43-), BeF3- and AlF4- as transition state analogues of 
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the γ phosphate. SMCcd did not crystallize in complex with ADP and orthovanadate. 
SMCcd together ADP-BeF3- or ADP- AlF4- crystallized under the same conditions as 
dimeric E1098Q SMCcd. Both crystals belong to the same space group and had 
comparable unit cell dimensions as the ATP bound dimer. Molecular replacement using 
one monomer of the ATP bound SMCcd resulted in a clear positive Fo-Fc density for 
ADP-BeF3- and ADP- AlF4- bound at the active center (Fig. 26). In the case of the 
ADP-BeF3- form the protein was better ordered and the structure could be refined to 
final R factors of 20.6 (24.1) whereas in the ADP- AlF4- larger parts of the protein were 
disordered and the structure was refined to slightly higher R factors of 22.6 (27.1). 
Statistics of data collection, structure solutions and refinement are listed in table 3 of 
the appendix. 
A) B)
 
Figure 26: Electron densities around ADP- AlF4- and ADP-BeF3-. 
A) In green the Fo-Fc density around ADP-AlF4- after replacement, rigid body refinement and 1 
cycle of positional refinement countered at 1σ. In blue the final 2Fo-Fc density at the same 
position countered at 1σ. B) Same figures as in A) for ADP-BeF3- with an additional water 
molecule positioned at the same place as in the ATP bound structure. 
 
6.3.4 SMCcd in complex with AP5A 
To investigate the molecular mechanism of the adenylate kinase activity of SMCcd the 
protein was co-crystallized with AP5A, a bisubstrate inhibitor of adenylate kinases. The 
screening for crystallization conditions resulted in long needles in almost all PEG 
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conditions. The conditions could be refined and crystals with the monoclinic space 
group P21 diffracted to a limiting resolution of 1.6 Å.  
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Figure 27: Crystals, diffraction and structure images of AP5A-SMCcd. 
A) Crystals of SMCcd bound to AP5A, B) Diffraction image of AP5A-SMCcd recorded at ESRF 
ID14-2. C) Chemical structure of AP5A (Na+ salt / image from Jena Bioscience). C) Well defined 
AP5A (red sticks) bound to one of the two molecules per asymmetric unit (color coded sticks with 
C atoms in green / C atoms in yellow: symmetry related molecule). The refined 2Fo-Fc electron 
density contoured at 1σ around the AP5A moiety is shown as blue mesh. 
 
Molecular replacement with a monomer of ATP bound SMCcd resulted in clashes in 
the region of the C-terminal helix. Using a truncated version of this molecule lacking 
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residues 1155-1169 yielded a clear 2Fo-Fc and Fo-Fc electron density for a whole AP5A 
moiety in one of the two molecules in the asymmetric unit. In the second molecule 
AP5A was partially disordered, presumably because the binding site of the second 
adenosine is located at a crystal contact. The data of structure solution and refinement 
are summarized in table 4 in the appendix. 
 
6.4 Structural analysis 
6.4.1 Overall structure of SMCcd 
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Figure 28: Ribbon presentation of the SMCcd crystal structure. 
Stereo view of SMCcd with annotated secondary structure elements. In red color the N-terminal 
part from N-N to C-N, in blue the C-terminal part starting at N-C and ending at C-C. The two 
lobes and the direction of the coiled-coil are labeled. 
 
The two peptide chains of SMCcd fold into one single globular domain consisting of 
two lobes with overall dimensions of 60x50x40 Å. Both lobes are joined by the central 
mixed parallel β-sheet formed by strand 3 and 8 of the N-terminal part and strand 12 
and 13 of the C-terminal part. Lobe I is mainly formed by the N-terminal segment of 
the protein and comprises the flanking antiparallel β-sheet comprising strands 2, 1, 4, 5, 
6 and 7. The central helix A is packed against this β-sheet and is connected via helix B 
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to strand 4 in this sheet. From the end of the sheet the peptide chain protrudes via 
helices C and D to the strand 8 of the central β-sheet and from there via E and F to the 
coiled-coil. The coiled-coil missing in this structure protrudes from lobe II and is 
inserted between helix F of the N-terminal fragment and helix G from the C-terminal 
fragment. Helix G already points in the direction of the coiled-coil whereas the peptide 
chain of helix F has to undergo an approximately 120° turn upwards to form the coiled-
coil. Lobe II comprises mainly the C-terminal part of the protein. Helices G, I and J are 
sandwiched between the central β-sheet and the outer sheet formed by strands 9, 10 and 
11. From the central β-sheet the chain continues through helix K and strands 14 and 15 
to a long C-terminal helix L. 
6.4.2 Structure of the ATP bound dimer 
Upon ATP binding E1098Q SMCcd dimerizes as shown by size exclusion 
chromatography (Fig. 18) but in the crystal the asymmetric unit contains only one 
molecule. After analyzing the crystal packing a dimer formed by two molecules related 
by a 2-fold crystallographic axis could be found (Fig. 29). 
90°
 
Figure 29: Two orthogonal views of dimeric SMCcd. 
Ribbon models of ATP bound SMCcd with one monomer colored in blue and the other in red. 
The two ATP molecules sandwiched in the interface are shown in color coded sticks. On the left 
side a top view of the dimer with the 2-fold symmetry axis indicated in the middle of the 
molecule. On the right hand side after a 90° rotation upwards a front view along the interface is 
shown with arrows indicating the direction of the coiled-coils. 
 
In the dimer two SMCcd molecules are oriented “head-to-tail” in which lobe I of one 
monomer binds to lobe II of the other monomer sandwiching two ATP molecules in 
their interface. This interface is situated along the long axis of the overall elliptic dimer. 
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The two coiled-coils protrude with an angle of approximately 45° and roughly 27 Å 
space at their root from the same face of the dimer. This concave surface is therefore 
the inner side of a protein ring formed by two SMC molecules and is defined as “top” 
of the molecule. The opposite convex side is the outer side of the ring and is formed on 
the bottom of the molecules by the two C-terminal helices extending to the other 
monomer. Dimerization is achieved by the binding of ATP to the Walker A motif of 
one protein and the signature motif of the opposing SMCcd. The buried surface of 
ATP-protein interactions contributes with 1800 Å2 in a similar amount to the dimer 
contact as the protein-protein contacts with 2600 Å2. In addition to the ATP-protein 
contacts there are some protein-protein interactions through direct hydrogen bonds 
(N35 to H1102/D1104; G36 to K1061/S1070; R1168 to D1105/D1131; H1102 to 
E/Q1098) and water mediated hydrogen bond networks. 
6.4.3 The active site 
The SMCcd dimer contains two active sites. These active sites are located at the dimer 
interface and are composed of residues from each SMCcd molecule. ATP is bound in a 
groove with the adenine pointing to the outside and the three phosphates pointing 
towards the middle of the complex. Residues surrounding this ATP binding site are 
highly conserved among SMC proteins and share high homology to the motifs 
characterizing an ABC ATPase (Fig. 30). 
The adenine moiety is specifically recognized by three main-chain hydrogen bonds, 
namely between N1 of the adenine and the main-chain N of residue A69, between N6 
of the adenine and the carbonyl O of residues I70 and D65. No interactions of the 
ribose with the protein molecule occur. The α and β phosphates are bound by the 
Walker A / P-loop. A Mg2+ ion binds to the β and γ phosphates. To saturate the 
octahedral coordination sphere of the Mg2+ ion it is additionally coordinated by S40 
and Q145 in one plane with the two phosphate oxygens and two water molecules above 
and below this plane. Residue D1097 stabilizes the coordination of the ion by binding 
to the lower water molecule and residue S40. 
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Figure 30: Conservation and ABC ATPase motifs mapped on the surface of SMCcd. 
Surface representation of the dimer interface of one molecule with bound ATP and Mg2+ (color 
coded sticks and magenta sphere). On the left side the degree of conservation is mapped on the 
surface with dark green for identical amino acids to white for non conserved residues (Alignment 
of SMC from Pyrococcus furiosus, Thermotoga maritima, Bacillus subtilis, human [SMC 1], 
Saccharomyces cerivisiae [SMC 1+2+3+4] with ClustalW). On the right hand side same view 
with ABC ATPase motifs mapped on the surface with red: Walker A; green: Walker B; orange: 
Q-loop; blue: Signature; dark green: D-loop. The coiled-coil protrudes upwards on the left side of 
the molecule. 
 
From the opposing molecule the adenine is not recognized, but there are two specific 
hydrogen bonds between residue K1064 and the 2’-OH and K1061 and the 3’-OH of 
the ribose. In addition the γ phosphate is bound by two hydrogen bonds from the 
signature motif S1070-Oγ and the main-chain N of G1072. 
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Figure 31: Stereo view of ATP bound to the active center. 
Color coded stick model of the active center of SMCcd with bound ATP, Mg2+ is shown as 
magenta sphere and the attacking water molecule as red sphere. Only one out of two 
symmetrically related composite active sites in the dimer interface is shown. One subunit is 
depicted with yellow, the other with green C atoms. Key side chains are labeled (see text for 
details) and notable hydrogen bonds are shown as dashed lines. 
 
For the hydrolysis of the ATP a water molecule carries out a nucleophilic attack on the 
γ phosphate. In the crystal structure a water molecule is observed that is poised for co-
linear attack on the scissile Pγ-O bond. This likely nucleophile is optimally positioned 
and activated by hydrogen bonds to Walker B E1098 (mutated to Q to facilitate 
crystallization) and the main-chain carbonyl O of H1102 form the H-loop / H-switch 
from the opposing subunit. 
6.4.4 Structural comparison between monomeric and dimeric SMCcd 
The nucleotide free and the ATP bound SMCcd can be superimposed with lsqman 
(Kleywegt, 1996) to a rmsd of only 0.99 Å for the Cα atoms, indicating clearly that 
there are only minor conformational changes upon ATP binding and dimerization (Fig. 
32). Only two regions show larger differences in the two SMCcd structures. This is on 
the one hand the C terminal helix that rotates away from the protein in the dimeric form 
(red helix in Fig. 32). Thereby steric clashes with the other protein are avoided and 
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after dimerization the helix spans towards the other subunit and takes part in protein-
protein interaction.  
 
Figure 32: Overlay of nucleotide free and ATP bound SMCcd. 
Stereo view of the backbone traces of nucleotide free SMCcd (gray) and ATP bound SMCcd 
(orange) superimposed using lsqman. The striking different parts, namely the R-loop and the C-
terminal helix are colored blue for the apo protein and red in the ATP bound structure.  
 
The largest rearrangement occurs at a surface loop in the vicinity of the ATPase site. In 
the nucleotide free crystal structure this loop spanning residues 50-80 is disordered and 
not visible in the electron density map (Fig. 32). After ATP binding this loop is ordered 
and forms helix B (Fig 32 and Fig. 28). 
 
6.4.5 The conserved arginine finger 
The R-loop that is ordered upon ATP binding and dimerization is located in the center 
at the concave side of the SMCcd dimer. As shown in figure 33 the R-loop contributes 
mainly to the positively charged surface region spanning the whole dimer in the inner 
side of a SMC ring. 
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Figure 33: Surface of dimeric SMCcd with mapped electrostatic potential and R-loop. 
On the left side top view of the ATP bound dimer (see Fig. 29). The electrostatic potential (-10 
kT/e [blue] to +10 kT/e [red]) is mapped on the solvent accessible surface. Bound ATP is shown 
in color coded sticks. On the right hand side same view with transparent surface and ribbon 
representation of the protein. The R-loop is shown as red sticks. The areas of the protruding 
coiled-coils are encircled. 
 
The loop is stabilized by R59 that is fixed in the dimer after ATP binding. This arginine 
finger directly hydrogen bonds to the α phosphate of the ATP. Sequence alignment of 
different SMC proteins from various species shows that this arginine finger is 
conserved among all SMC proteins (Fig.34). 
Pf SMC   30 AIVGANGSGK SNIGDAILFV LGGLSAKAMR AS
Tm SMC   28 AIVGPNGSGK SNIIDAIKWV FGEQSKKELR AS
Bs SMC   28 AVVGPNGSGK SNITDAIRWV LGEQSARSLR GG
Xl SMC  112 FVIGNNGSGK SAVLTALIVG LGGKAAITNR GS
hu SMC1  29 AIIGPNGSGK SNLMDAISFV LGEKTSN-LR VK
Sc SMC1  30 SIIGPNGSGK SNMMDAISFV LG-VRSNHLR SN
Sc SMC2  29 AITGLNGSGK SNILDAICFV LGIASMSTVR AS
Sc SMC3  29 VIIGSNGSGK SNFFAAIRFV LSDDYSNLKR EE
Sc SMC4 182 AVVGPNGSGK SNVIDSMLFV FG-FRANKMR QD
SC SMC5  66 MIIGPNGSGK STFVCAVCLG LAGKPEYIGR SK
Sc SMC6 106 FIVGNNGSGK SAILTAITIG LGAKASETNR GS
R-loopWalker A
 
Figure 34: Detail view of the R-loop and alignment of the arginine finger. 
Detailed stereo view of a ribbon model of SMCcd with the R-loop colored in red. The arginine 
finger R59 and ATP are shown as color coded sticks with the hydrogen bond as dashed line 
(Mg2+: magenta sphere). On the right side sequence alignment (ClustalW (Thompson et al., 
1994)) showing that the arginine finger (highlighted in red) in the R-loop is conserved among 
SMC proteins. Pf: Pyrococcus furiosus; Tm: Thermatoga maritima; Bs: Bacillus subtilis; hu: 
human; and Sc: Saccharomyces cerevisiae. 
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6.4.6 Structures with bound transition state analogues 
When the SMCcd structures with bound transition state analogues are superimposed 
with ATP bound structure the overall rmsd for the Cα atoms varias between 0.36 (ATP 
to ADP-BeF3-) and 0.53 (ADP-AlF4- to ADP-BeF3-) indicating highly similar structures 
with only minor reorganizations. In addition SMCcd with bound ADP- BeF3- and ADP-
AlF4- is packed in the crystal in the same way as the ATP bound SMCcd. Applying the 
2-fold symmetry operation used in the ATP form results in a dimer similar to the ATP 
induced dimer. 
G1071 G1071
E/Q1098 E/Q1098Q145 Q145
H1102 H1102
S1070 S1070
S40 S40
 
Figure 35: Superimposed active site of SMCcd bound to ATP, ADP-AlF4- and ADP-BeF3-. 
Stereo view of the active site with bound ATP, ADP-AlF4- and ADP-BeF3- with key residues 
shown as color coded sticks green: ATP form; yellow: ADP-AlF4- form; blue: ADP-BeF3- form. 
The Mg2+ ions are depicted as magenta spheres and the attacking water molecules in red. 
 
In the ADP-AlF4- bound structure helices E and F are not ordered. Inspection of the 
active center reveals no indication for a conformational change which might lead to 
rearrangement of this region. The key residues at the active site responsible for the ATP 
binding and hydrolysis adopted equal conformation in all three structures and hold ATP 
/ ADP-AlF4- / ADP-BeF3- and the Mg2+ ion in quasi identical positions. Only the 
activating E1098 and the attacking water molecule vary slightly in their position in 
response to the additional charge and the altered shape of the ligands.  
6.4.7 Structure of SMCcd in complex with AP5A 
AP5A as a bi-substrate inhibitor of adenylate kinases blocks two sites at the enzyme: 
one adenosine binds the ATP site (from now adenosine 1), while the other adenosine 
binds the AMP site (from now adenosine 2) in the situation of the forward reaction. In 
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the crystal structure of SMCcd in complex with AP5A the inhibitor adopts a double 
bend “S” like conformation (Fig. 36). Adenosine 1 plus α, β and γ phosphates and one 
Mg2+ ion bind to the canonical ATP binding site of lobe I of SMCcd with an identical 
arrangement as in the ATP bound structure. The adenine 1 is specifically recognized 
and bound by hydrogen bonds to the main chain at residues 66-68. The α and β 
phosphates are bound by the Walker A motif / P-loop and the conserved R59 of the 
arginine finger.  
 
Figure 36: Binding of AP5A to SMCcd. 
Stereo view of the bi-substrate inhibitor AP5A bound to SMCcd both represented as color coded 
stick models. Selected motifs, amino acids, water molecules (red spheres), hydrogen bonds 
(dashed lines) the Mg2+ ion (grey sphere) are annotated. 
 
The coordination of the Mg2+ ion is similar to that of the ATP bound structure. Two 
coordination sites of the Mg2+ are occupied by oxygens of the β and γ phosphates. The 
coordination sphere of the Mg2+ ion is completed by side chain oxygen of Q145, S40 
(Walker A) and two water molecules. The δ and ε phosphates are not recognized by the 
protein. Ribose 2 is bound by the C-terminal helix of the protein. This tail is not 
conserved among ABC proteins and thus this interaction might be due to crystal 
contacts. However, the C-terminal helix occupies the position of the D-loop from the 
opposing NBD in the dimeric form and thus the D-loop interacts with the AMP site. 
Adenine 2 is bound to the interface of lobe I and II. The AMP site is formed on the one 
hand by the side chain of Q145 (Q-loop). Adenine 2 stacks onto the carboxamide 
moiety of Q145 in a similar manner as the interaction of adenine 1 with the K13-S14 
peptide bond. In addition the N6 amine and N7 nitrogen of adenine 2 form two 
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hydrogen bonds to a Mg2+ ion water ligand (W1 in Fig. 36). Finally the N4 nitrogen 
binds the Q145 main chain carbonyl via a water molecule (W3 in Fig. 36). 
AP5A
ATPLobe II Lobe I
P-loop
Mg2+
A1
A2
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Q-loop
A B
15°
Lobe ILobe II
 
Figure 37: Comparison of ATP and AP5A bound structures of SMCcd. 
Ribbon representation of the ATP bound (blue) and AP5A bound (red) structure of SMCcd with 
the ligand in color coded stick model. A) Active site view of the overlaid structures. The two 
Adenosins are denoted with A1 and A2, the two Mg2+ ions are shown as spheres and the three 
important binding sites P-loop, Q-loop and C tail (CT) are labeled. B) Domain view of the 
superposition with the color code of A).The opposing NBD in the ATP bound dimer is shown in 
light blue. Lobe II rotates in the AP5A bound structure ~15° relative to lobe I in comparison to the 
ATP bound structure. 
 
Superposition of the AP5A bound structure to the ATP bound structure shows a virtual 
identical arrangement of lobe I, the ATP and the adenosine I plus the α, β and γ 
phosphates respectively in both structures. However, in the AP5A structure lobe II is 
rotated ~15° relative to lobe I in respect to the ATP structure due to the fact that the 
conformation of the Q-loop is different in both structures. 
The relevance of these findings for the adenylate kinase activity of other ABC ATPases 
was further supported by comparison of the structure with known structures of two 
other ABC ATPases. In the CFTR protein the mutation N1303K in the NBD2 involved 
in cystic fibrosis disease abolishes the adenylate kinase activity (Randak and Welsh, 
2003). Comparing the structure of AP5A bound SMCcd with the known structure of 
the NBD1 of mouse CFTR reveals that this in both NBD conserved glutamine (N505 in 
NBD1) binds the main chain thereby stabilizing the β-strand that follows the Q-loop 
(Fig. 38 A). Mutations of this residue in the NBD2 might lead to a destabilization of the 
whole region and perturb the AMP binding site by affecting the Q-loop. 
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Figure 38: Comparison of AP5A bound SMCcd to CFTR NBD1 and ABCE1. 
A) Stereo view of the overlay of the AP5A bound SMCcd structure (light blue) to the structure of 
CFTR NBD1 (grey - PDB ID 1ROX). AP5A, Q-loop glutamine and N505 are depicted as color 
coded sticks and Mg2+ as magenta sphere. B) Stereo view of the superposition of AP5A bound 
SMCcd and ABCE1 (red - PDB ID 1YQT) as ribbon presentation. AP5A, the Q-loop glutamine 
and Tyr407 are shown as color coded sticks and Mg2+ as magenta sphere. 
 
The ABCE1 ABC ATPase has a conserved tyrosine next to the Q-loop glutamine. 
Superposition of ABCE1 with the AP5A bound SMCcd shows that this residue points 
towards the putative AMP binding site (Fig. 38 B). The tyrosine thereby specifically 
blocks the adenine binding surface of the Q-loop glutamine and impedes adenylate 
kinase activity of ABCE1. 
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7 Discussion 
Accurate propagation of genetic information during cell division requires proper DNA 
replication and three other important processes: DNA repair by recombination, sister 
chromatid cohesion and chromosome condensation. Proteins of the structural 
maintenance of chromosomes (SMC) protein family play a key role in each of these 
three processes by forming the core of the involved multiprotein complexes. SMC 
proteins are highly conserved and present in all kingdoms of life. The outstanding role 
of this protein family arises from their unique architecture that allows them to span 
long distances and form large proteinous rings. Sequence analysis revealed a ~500 Å 
long coiled-coil joining an ABC ATPase domain on one end and a hinge domain on the 
other end. SMC proteins require ATP binding and hydrolysis to promote cohesion and 
condensation, which is suggested to proceed via formation of SMC ring assemblies 
(Arumugam et al., 2003; Bazett-Jones et al., 2002; Kimura and Hirano, 1997; Weitzer 
et al., 2003). 
To gain insights into the function of SMC proteins the molecular structure of the 
protein should be solved. However, the expression and purification of eukaryotic 
proteins is challenging due to complexity and different codon usage. A good way to 
overcome this problem in protein crystallography is the use of archaeal homologous. 
Archaeal proteins show high sequence similarity to eukaryotic proteins but have better 
properties such as thermo stability and lack of flexible regions. Furthermore, eukaryotic 
genomes contain several genes for SMC proteins that form heterodimers. In archaeal 
genomes only a single SMC protein is encoded and therefore they function as 
homodimers. This fact facilitates structural and biochemical analysis. Pyrococcus 
furiosus (Pfu) lives at elevated temperatures that request highly stable proteins and was 
therefore chosen as source organism in this work. For crystallization another problem 
arises as the SMC proteins share a characteristic three domain architecture with a 
central coiled-coil domain that has a high flexibility in regard to its arrangement as seen 
in electron microscopy (Fig. 5)(Haering et al., 2002; Hopfner et al., 2000; Melby et al., 
1998). This conformational heterogeneity would impede crystallization where great 
homogeneity is a prerequisite for proper three dimensional arrangement of the proteins. 
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To overcome this problem only the catalytically active nucleotide binding domain 
(NBD) was used for crystallization. The residues building up the NBD were determined 
computer based using a web tool for coiled-coil prediction (Lupas et al., 1991). The 
coiled-coil and hinge domain forming the central part of the polypeptide chain were 
omitted from the protein. Amino acids forming the globular NBD can be found at the 
very N- and C-terminal part of the protein and were expressed as two fragments 
without a linker in a modified vector for bicistronic expression (Hoeppner, 2005). The 
two protein chains (aa 1-182 and 1006-1177) could be expressed in E.coli and form a 
single globular domain as indicated by heat stability, association throughout the whole 
purification procedure and the apparent molecular weight on the size exclusion column. 
The resulting protein was crystallized and the structure was solved by de novo phasing 
to obtain best possible phases to a limiting resolution of 2.0 Å. The nucleotide binding 
domain of Pfu SMC adopts a two lobe conformation. Lobe I is formed by the N-
terminal part of the protein and contains a central helix wrapped by a large ß sheet. The 
C-terminal residues form the mainly α helical lobe II. The two lobes are connected via 
a central four stranded ß sheet composed of two ß strands of both of the protein chains. 
Together with helices E and F, which extend from lobe I across lobe II, these extensive 
interactions explain why the N- and C-terminal part of the Pfu SMC proteins form a 
stable nucleotide binding domain upon co-expression. This stable interaction of the two 
parts of the protein is essential in nature to ensure functionality of the protein at 
elevated temperatures and thereby allow growth of Pyrococcus furiosus. The coiled-
coil missing in the construct protrudes from lobe II in extension of helix G. Helix F is 
not yet oriented in direction of the coiled-coil and therefore the protein chain has to turn 
upwards to be able to interact with the extension of helix G. Comparison with other 
ABC ATPase structures reveals that this two helices are conserved among them and the 
coiled-coil can be therefore regarded as an insertion into the loop between these two 
helices. The structural similarity of the Pfu SMC NBD to other ABC ATPase structures 
is striking. Especially it has not only a high similarity to the structures of the NBDs of 
Pfu Rad50 and Thermotoga maritima SMC, both archaeal proteins, but also to the 
eukaryotic Saccharomyces cerevisiae SMC1 indicating that results obtained on the Pfu 
protein can serve as a model for all SMC proteins (Haering et al., 2004; Hopfner et al., 
2000; Lowe et al., 2001). 
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To understand the role of ATP the protein was crystallized in the presence of ATP. No 
Crystals were obtained with none or slowly hydrolysable ATP analogues such as 
ATPγS and AMP-PNP, which might be due to their slightly different sterical 
properties. For crystallization of the ATP bound complex, it was necessary to introduce 
the Walker B motif mutation E1098Q, which traps the ATP complex of proteins. This 
mutation strongly reduces the ATPase activity of the NBD as shown in the ATPase 
assays. The reduced ATPase activity leads to formation of a dimeric ATP-protein 
complex as judged by the increased Stoke’s radius on a size exclusion column. A 
complex of the same size but in a lower fraction compared to monomeric SMCcd could 
be obtained by incubating wild type protein with ATPγS. This lower occurrence of 
dimeric protein in the prescence of ATPγS in comparison to ATP might explain the 
inability of crystal formation. 
Inspection of the crystal packing revealed that a SMCcd-SMCcd homodimer with two 
sandwiched Mg2+-ATP moities assembled along the crystallographic 2-fold axis. The 
two SMCcd domains are arranged “head-to-tail” creating two active sites in the dimer 
interface. This “head-to-tail” dimerization where lobe I of one monomer interacts with 
lobe II of the other was first shown for Pfu Rad50cd and MutS to be the functional 
arrangement of ABC ATPases (Hopfner et al., 2000; Lamers et al., 2000; Obmolova et 
al., 2000). Only in this orientation Walker A and Walker B motif from one SMCcd 
subunit and the signature motif from the opposing SMCcd come together and form a 
composite active site. The interaction of the Walker A motif of one subunit with the 
adenine ring and hydrogen bonding of the signature motif of the opposing molecule to 
the γ phosphate is the main driving force for the dimerization. Overall the buried 
surface between ATP and protein contributes with 1800 Å2 in a similar amount to the 
dimer interface as the 2600 Å2 buried surface between the proteins. Thus, assuming the 
ring model for the arrangement of the SMC dimer in the cell, ATP binding is the major 
driving force of ring closing and ATP hydrolysis the reason for ring opening at the 
nucleotide binding domains of the proteins.  
ATP hydrolysis by ABC ATPases is achieved by the nucleophilic attack of a water 
molecule at the γ phosphate, subsequent disengagement of the dimer and release of 
ADP and Pi. In the SMCcd complex structure a water molecule is poised for collinear 
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attack on the scissile bond between the β and γ phosphate. Positioning and activation of 
the water is achieved by cooperation of the two subunits. One SMCcd provides the 
Walker B glutamic acid (E1098) and the opposing subunit contributes a backbone 
carbonyl oxygen from a histidine (H1102). The contributions to positioning and 
activation of the nucleophile from both subunits suggest that ATP hydrolysis only takes 
place in the engaged SMCcd dimer. These findings are supported by mutagenesis data 
showing that disengagement of the dimer interaction by introducing a bulky arginine 
instead of a serine (S1070R) at the dimer interface abolishes ATP hydrolysis. The 
important role of the Walker B residue E1098 could be strikingly supported by 
mutating this residue to a glutamine as in the protein used for crystallization of the ATP 
complex. Changing the carboxyl group into an amide group strongly reduces ATPase 
activity of SMCcd. 
 
Figure 39: ATPase cycle of SMC proteins with functional mutations. 
Each SMC head domain binds one ATP molecule (red; green: ADP). Mutating the Walker A 
lysine impairs nucleotide binding. ATP binding promotes dimerization which is prevented by 
introducing a bulky arginine at the position of the signature motif serine. The following ATP 
hydrolysis reaction can be disturbed by mutating the Walker B glutamic acid to a glutamine. DNA 
stimulation of the ATPase activity is abolished when the arginine finger is mutated. (adopted from 
(Losada and Hirano, 2005)) 
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The cycle of ATP binding, ATP hydrolysis and nucleotide release (Fig.39) induces a 
conformational change within the ABC domain in many ABC enzymes, especially in 
ABC transporter and Rad50. This conformational switch was denoted as “power 
stroke” and is transmitted to the substrate specific domains of the ABC ATPase to drive 
the enzymatic cycle (Hopfner and Tainer, 2003). Comparison of the nucleotide free 
form, the ATP bound form and SMCcd bound to transition state analogues revealed 
very similar overall conformations in all states of the catalytic cycle. This indicates that 
SMC proteins do not possess a “power stroke” that lead to conformational changes 
throughout the molecule. In fact ATP binding and hydrolysis by SMC proteins seems 
to be limited to the closing and opening of the SMC protein rings or other higher order 
assemblies. However, there are two regions that change their conformation upon ATP 
binding and dimerization. The C-terminal helix L rotates away from the ABC domain 
and binds to the opposing subunit. This rearrangement points towards a role of this 
helix in the control of SMCcd association and ATPase activity by additional non-SMC 
subunits (Hirano and Hirano, 2004). A second conformational change is observed in a 
surface loop. Upon ATP binding this loop is ordered by the binding of an arginine to 
the α phosphate. In the nucleotide free form of SMCcd this loop is partially disordered. 
The R-loop is located at the center of the positively charged surface at the concave side 
of the SMCcd dimer on lobe I and is strictly conserved among all SMC proteins. The 
ATP driven conformational variability and the location in the center of a positively 
charged surface suggests that the R-loop is a good candidate for the coupling of 
ATPase activity to interaction of the protein with DNA. An equivalent positively 
charged region has been implicated in DNA binding by Rad50 (Hopfner et al., 2001). 
To test the effect of DNA on SMCcd the ATPase activity was assayed in the absence 
and presence of dsDNA on wild type and mutant protein. The basal ATPase activity of 
wt Pfu SMCcd in the absence of DNA is weak but strongly stimulated in the presence 
of dsDNA. A similar DNA dependent stimulation of ATPase activity was observed for 
both bacterial and eukaryotic multisubunit SMC protein complexes, suggesting that this 
DNA stimulation directly acts on the ABC domains in SMC complexes (Hirano et al., 
2001; Kimura and Hirano, 1997). Mutating the conserved arginine finger (R59) to an 
alanine has no effect on the basal ATPase activity but completely abolishes the 
stimulating effect of dsDNA approving its role in coupling DNA interaction to ATP 
Discussion 71 
 
 
 
hydrolysis. The R-loop might be rearranged upon DNA interaction and R59 directed 
towards the ATP where it most likely counterbalances the developing negative charge 
during ATP hydrolysis. The structural and mechanistic role of the arginine finger 
shows remarkable analogy to the activation of small GTPases by GTPase activating 
proteins (GAPs). GAPs insert into the active site of G proteins an arginine finger that 
both binds GTP and stimulates GTP hydrolysis (Ahmadian et al., 1997; Scheffzek et 
al., 1997).  
In vivo it was shown that this arginine finger plays indeed an important role in the 
biological function of yeast cohesin (Lengronne et al., 2006). Strains lacking the 
arginine finger in either SMC1 or SMC3 are moderately threatened by chromosome 
loss. Cells with the arginine mutated to an alanine in both SMC1 and SMC3 are viable 
but show dramatically increased chromosome instability. The fact that the cells with 
altered DNA stimulation are still viable provided a great tool for investigating the 
establishment of sister chromatid cohesion in the living cell. Measuring the kinetics of 
wild type and mutant cohesin loading onto chromosomes showed dramatically delayed 
association of the SMC complexes lacking the arginine in comparison to the wild type 
complex during G1 phase. However, mutating the arginine finger has no effect on the 
establishment of sister chromatid cohesion in S phase. These findings point towards a 
role of the R-loop in the initial loading of the SMC complexes onto DNA. Recent data 
suggest that this loading might be achieved by stepwise transport of the DNA through 
the hinge (Gruber et al., 2006). To allow DNA entry the hinge domain presumably has 
to interact with the head domains that are dimerized upon ATP binding. After passage 
of a DNA strand ATP is hydrolyzed and the hinge to head interaction is reversed (Fig. 
40). In the case of cohesin this loading might be restricted to only one DNA strand per 
SMC ring whereas in the case of condesin several cycles of ATP binding – DNA 
loading – ATP hydrolysis are conceivable that trap loops of DNA to condensate the 
chromosome. Head domains missing the arginine finger have presumably an altered 
and less defined surface. They provide an insufficient interaction area to the hinge and 
thereby hinder an efficient loading of SMC rings onto DNA. After ATP hydrolysis the 
closing of the ring might be achieved by non-SMC proteins, e.g. Scc1 in the cohesin 
complex. For the establishment of sister chromatid cohesion two models are possible. 
The whole or parts of the replication machinery slide through the ring or on the other 
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hand the ring is transiently opened and closed again after the replication fork. So far no 
evidence for the latter has been found but it must be different from the first loading 
because the arginine finger mutations have no influence at this stage (Lengronne et al., 
2006). 
 
Figure 40: Model for the establishment of sister chromatid cohesion. 
ATP (red) binding to the head domains leads to their dimerization. The hinge domain interacts 
with the inner surface of the dimerized head domains. Upon this interaction DNA can be passed 
sequentially through the hinge in the inner side of the SMC ring. The DNA now interacts with the 
arginine finger and allosterically activates the hydrolysis of ATP. This reaction impairs the head 
to head and head to hinge interactions. The ring is now closed by Scc1 proteins (orange). After the 
replication machinery (green) duplicated the chromosomes both sister chromatides are held 
together till the cleavage of Scc1 at the onset of anaphase. In the case of condensin the cycle of 
ATP binding – DNA gating – ATP hydrolysis might be run through several times to loop the 
DNA. 
 
However, other modes of association of SMC complexes with DNA are possible. So far 
it is not clear if the huge structural rearrangement of the coiled-coil needed for the 
hinge to head interaction really occurs, although it was observed in some atomic force 
microscopy studies (Sakai et al., 2003; Yoshimura et al., 2002). Furthermore, this 
model does not explain why ATP hydrolysis is essential for cohesin loading. For the 
Bacillus subtilis SMC a sitting model is proposed were the DNA interacts with the 
hinge and is subsequently loaded through the head domains (Shintomi and Hirano, 
2007). Taking the high sequence and structure similarity between the different SMC 
proteins from different organisms into account it is unlikely that their function is based 
on such different mechanisms. In addition the role of essential loading factors, in yeast 
for example Eco1, Ctf4 and Ctf18, is completely unknown so far (Lengronne et al., 
2006; Milutinovich et al., 2007; Toth et al., 1999). The DNA might be directly gated 
through the head domains across the non-SMC subunits assisted by loading factors. 
Besides for Scc1 not much is known at structural and functional level about the non-
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SMC proteins involved in the SMC complexes, too (Haering et al., 2004). Scc1 serves 
in the cohesin complex as a bridge between the head domains of SMC1 and SMC3 and 
is cleaved by a protease named separase on anaphase onset to allow sister chromatid 
separation (Uhlmann, 2001; Uhlmann et al., 2000). In bacteria ScpA and ScpB are the 
known subunits of the SMC complexes that share only weak sequence homology to 
eukaryotic non-SMC subunits. In Pyrococcus furiosus the gene for ScpA overlaps with 
the gene for SMC protein. This protein forms a tight complex with SMCcd but does not 
lead to higher order complexes in vitro than ScpA SMCcd dimers indicating that it has 
not a bridging function like Scc1. The interaction of SMCcd with ScpA had no 
significant influence on its ATPase activity although in Bacillus subtilis a moderately 
reduced activity was observed (Hirano and Hirano, 2004). In any case the SMCcd-
ScpA complex also shows pronounced DNA stimulated ATPase activity, which is 
specifically abolished by the arginine finger mutation. Thus the DNA stimulated 
ATPase activity of SMCcd appears to be independent of its association with ScpA. A 
gene for a presumable homologue of ScpB was found apart from the two other genes in 
the genome. The protein encoded by this gene does neither form a stable complex with 
SMCcd nor with ScpA. Assuming that it is really the ScpB homologue it might interact 
with the missing coiled-coil of the SMC protein to form a complex or additional 
proteins mediate the complex formation. 
One important question remains when analyzing the mechanism of SMC proteins. Why 
does the process of DNA trapping require the energy of ATP hydrolysis although no 
power stroke could be observed at the ABC ATPase domain? A similar question arose 
by investigations on the CFTR ion channel. This transmembrane protein regulates the 
passive flow of anions down an electrochemical gradient (Vergani et al., 2005a). CFTR 
belongs to the ABC ATPase family of proteins and its two NBD can hydrolyse ATP in 
vitro (Vergani et al., 2005b). At physiological nucleotide concentrations, however, the 
channel is efficiently regulated by the reversible adenylate kinase reaction (Gross et al., 
2006; Randak and Welsh, 2003; Randak and Welsh, 2005). The adenylate kinase 
reaction releases virtually no free energy under cellular nucleotide concentrations 
consistent with the lacking necessity for energy consumption during a passive ion 
gating function. The presence of the distinct ATP hydrolysis and adenylate kinase 
activities within the ABC protein family is puzzling because CFTR possesses all the 
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typical ATP hydrolysis motifs. Furthermore the molecular mechanism of adenylate 
kinase activity remains unclear. Thus, to provide a mechanistic framework for 
understanding the evolution of adenylate kinase activity in ABC enzymes we 
biochemically and structurally analyzed the adenylate kinase properties on Pfu SMCcd. 
While the forward adenylate kinase reaction (ATP + AMP ? 2 ADP) was masked by 
the much more robust ATPase activity, the formation of ATP out of ADP could be 
shown using a luciferase assay. The much higher rate of ATP hydrolysis argues that 
SMC proteins in vivo hydrolyze ATP rather than being regulated by an adenylate 
kinase activity. Nevertheless, the finding that SMCcd is able to catalyze the reverse 
adenylate kinase reaction raises the possibility that in principle all ABC ATPases have 
this activity. For structural analysis SMCcd was crystallized in complex with AP5A a 
bisubstrat inhibitor of adenylate kinases that also inhibited the adenylate kinase reaction 
of SMCcd. Inspection of the structure clearly showed that residues responsible for the 
binding of AP5A and therefore involved in the catalytic reaction belong to the 
conserved ABC ATPase motifs. One adenosine plus three phosphates bind to the 
canonical ATP binding site of lobe I at the Walker A and B motifs. Adenosine 2 stacks 
onto the side chain of the conserved Q-loop glutamine and is discriminated by 
hydrogen bonding to the Mg2+ and the glutamine. Together the later interaction could 
explain the inability of GMP to substitute AMP in CFTR (Gross et al., 2006; Randak 
and Welsh, 2003). Mutant analysis revealed that not only Walker A and the Q-loop but 
in addition the signature motif is required for activity suggesting that the reaction 
occurs in the engaged dimer as it was shown for the ATPase reaction. In the structure 
the attacking Pε is not correctly positioned. This might be due to the additional 
phosphate in AP5A in contrast to the substrates in this reaction containing only four 
phosphates. Comparing the AP5A bound structure with the ATP bound form revealed a 
second possible way of regulation upon adenylate kinase reaction besides the 
dimerization. The presence of AP5A leads to a 15° rotation of lobe II in respect to lobe 
I accompanied by a reorientation of the Q-loop. Thus, AMP binding to CFTR could 
also help to orient lobes I and II, a process that may follow or facilitate engagement of 
the NBDs in response to ATP binding. Since the TMDs of ABC transporters bind near 
the lobe interface, both NBD engagement and rotation of the lobes relative to each 
other could contribute to channel opening. Comparison of the structure of SMCcd 
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bound to AP5A with the structure of the NBD1 of CFTR explains the effect of the 
N1303K mutation in NBD2 that abolishes adenylate kinase activity of CFTR in vitro 
and lead to cystic fibrosis. The corresponding residue in NBD1 (N505) binds the main 
chain and stabilizes a strand that follows the Q-loop supposing that a mutation could 
perturb the proposed AMP binding site. In ABCE1 the possible AMP binding site is 
blocked and thereby the adenylate kinase reaction is disabled. Taken together these 
findings suggest that all ABC enzymes can catalyze both the ATPase and the adenylate 
kinase reaction but differently utilize them in nature. During evolution the existing 
motifs were altered in a way that one or the other reaction is favored. 
 
Figure 41: Unifying model for the ATPase and adenylate kinase activity. 
Selected protein motifs, nucleotides and the active site magnesium are schematically shown. The 
proposed nucleophilic attacks of the water during hydrolysis (A) or phosphate oxygens for the 
adenylate kinase reaction (B) are indicated. In both cases the ATP is bound by the Walker A / P-
loop of one protomer and by the signature motif of the opposing NBD via the γ phosphate. For 
ATP hydrolysis a water molecule is positioned and activated for nucleophilic attack by the 
Walker B motif of one protomer and the D-loop of the second protein. In the proposed adenylate 
kinase reaction the adenine of AMP/ADP binds the Q-loop and coordinates the magnesium 
facilitating the nucleophilic attack of the phosphate oxygen. In both cases the helices of the P-loop 
and signature motif compensate for the increased negative charge during reaction. 
 
References 76 
 
 
 
8 References 
Ahmadian, M. R., Stege, P., Scheffzek, K., and Wittinghofer, A. (1997). Confirmation of the 
arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras. Nat 
Struct Biol 4, 686-689. 
Arumugam, P., Gruber, S., Tanaka, K., Haering, C. H., Mechtler, K., and Nasmyth, K. (2003). 
ATP hydrolysis is required for cohesin's association with chromosomes. Curr Biol 13, 
1941-1953. 
Bazett-Jones, D. P., Kimura, K., and Hirano, T. (2002). Efficient supercoiling of DNA by a 
single condensin complex as revealed by electron spectroscopic imaging. Mol Cell 9, 
1183-1190. 
Bisbal, C., Martinand, C., Silhol, M., Lebleu, B., and Salehzada, T. (1995). Cloning and 
characterization of a RNAse L inhibitor. A new component of the interferon-regulated 
2-5A pathway. J Biol Chem 270, 13308-13317. 
Blow, D. (2002). Outline of Crystallography for Biologists (New York: Oxford University 
Press ). 
Bradley, G., Juranka, P. F., and Ling, V. (1988). Mechanism of multidrug resistance. Biochim 
Biophys Acta 948, 87-128. 
Bricogne, G., Vonrhein, C., Flensburg, C., Schiltz, M., and Paciorek, W. (2003). Generation, 
representation and flow of phase information in structure determination: recent 
developments in and around SHARP 2.0. Acta Crystallogr D Biol Crystallogr 59, 2023-
2030. 
Britton, R. A., Lin, D. C., and Grossman, A. D. (1998). Characterization of a prokaryotic SMC 
protein involved in chromosome partitioning. Genes Dev 12, 1254-1259. 
Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. 
W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998). Crystallography 
& NMR system: A new software suite for macromolecular structure determination. 
Acta Crystallogr D Biol Crystallogr 54, 905-921. 
Carson, D. R., and Christman, M. F. (2001). Evidence that replication fork components 
catalyze establishment of cohesion between sister chromatids. Proc Natl Acad Sci U S 
A 98, 8270-8275. 
CCP4, N. (1994). The CCP4 suite: programs for protein crystallography. Acta Crystallogr D 
Biol Crystallogr 50, 760-763. 
Chuang, P. T., Albertson, D. G., and Meyer, B. J. (1994). DPY-27:a chromosome condensation 
protein homolog that regulates C. elegans dosage compensation through association 
with the X chromosome. Cell 79, 459-474. 
Ciosk, R., Shirayama, M., Shevchenko, A., Tanaka, T., Toth, A., Shevchenko, A., and 
Nasmyth, K. (2000). Cohesin's binding to chromosomes depends on a separate complex 
consisting of Scc2 and Scc4 proteins. Mol Cell 5, 243-254. 
Dervyn, E., Noirot-Gros, M. F., Mervelet, P., McGovern, S., Ehrlich, S. D., Polard, P., and 
Noirot, P. (2004). The bacterial condensin/cohesin-like protein complex acts in DNA 
repair and regulation of gene expression. Mol Microbiol 51, 1629-1640. 
Drenth, J. (1999). Principles of Protein X-ray Crystallography (Heidelberg: Springer Verlag). 
Emsley, P., and Cowtan, K. (2004). Coot: model-building tools for molecular graphics. Acta 
Crystallogr D Biol Crystallogr 60, 2126-2132. 
References 77 
 
 
 
Engh, R. H., R. (1991). Accurate bond and angle parameters for x-ray protein structure 
refinement. Acta Crystallogr D Biol Crystallogr A47, 392-400. 
Fujioka, Y., Kimata, Y., Nomaguchi, K., Watanabe, K., and Kohno, K. (2002). Identification 
of a novel non-structural maintenance of chromosomes (SMC) component of the 
SMC5-SMC6 complex involved in DNA repair. J Biol Chem 277, 21585-21591. 
Gerlich, D., Hirota, T., Koch, B., Peters, J. M., and Ellenberg, J. (2006). Condensin I stabilizes 
chromosomes mechanically through a dynamic interaction in live cells. Curr Biol 16, 
333-344. 
Gillespie, P. J., and Hirano, T. (2004). Scc2 couples replication licensing to sister chromatid 
cohesion in Xenopus egg extracts. Curr Biol 14, 1598-1603. 
Graumann, P. L. (2000). Bacillus subtilis SMC is required for proper arrangement of the 
chromosome and for efficient segregation of replication termini but not for bipolar 
movement of newly duplicated origin regions. J Bacteriol 182, 6463-6471. 
Graumann, P. L. (2001). SMC proteins in bacteria: condensation motors for chromosome 
segregation? Biochimie 83, 53-59. 
Gross, C. H., Abdul-Manan, N., Fulghum, J., Lippke, J., Liu, X., Prabhakar, P., Brennan, D., 
Willis, M. S., Faerman, C., Connelly, P., et al. (2006). Nucleotide-binding domains of 
cystic fibrosis transmembrane conductance regulator, an ABC transporter, catalyze 
adenylate kinase activity but not ATP hydrolysis. J Biol Chem 281, 4058-4068. 
Gruber, S., Arumugam, P., Katou, Y., Kuglitsch, D., Helmhart, W., Shirahige, K., and 
Nasmyth, K. (2006). Evidence that Loading of Cohesin Onto Chromosomes Involves 
Opening of Its SMC Hinge. Cell 127, 523-537. 
Haering, C. H., Lowe, J., Hochwagen, A., and Nasmyth, K. (2002). Molecular architecture of 
SMC proteins and the yeast cohesin complex. Mol Cell 9, 773-788. 
Haering, C. H., Schoffnegger, D., Nishino, T., Helmhart, W., Nasmyth, K., and Lowe, J. 
(2004). Structure and stability of cohesin's Smc1-kleisin interaction. Mol Cell 15, 951-
964. 
Hagstrom, K. A., Holmes, V. F., Cozzarelli, N. R., and Meyer, B. J. (2002). C. elegans 
condensin promotes mitotic chromosome architecture, centromere organization, and 
sister chromatid segregation during mitosis and meiosis. Genes Dev 16, 729-742. 
Hanahan, D. (1983). Studies on transformation of Escherichia coli with plasmids. J Mol Biol 
166, 557-580. 
Higgins, C. F., Haag, P. D., Nikaido, K., Ardeshir, F., Garcia, G., and Ames, G. F. (1982). 
Complete nucleotide sequence and identification of membrane components of the 
histidine transport operon of S. typhimurium. Nature 298, 723-727. 
Hirano, M., Anderson, D. E., Erickson, H. P., and Hirano, T. (2001). Bimodal activation of 
SMC ATPase by intra- and inter-molecular interactions. Embo J 20, 3238-3250. 
Hirano, M., and Hirano, T. (1998). ATP-dependent aggregation of single-stranded DNA by a 
bacterial SMC homodimer. Embo J 17, 7139-7148. 
Hirano, M., and Hirano, T. (2002). Hinge-mediated dimerization of SMC protein is essential 
for its dynamic interaction with DNA. Embo J 21, 5733-5744. 
Hirano, M., and Hirano, T. (2004). Positive and negative regulation of SMC-DNA interactions 
by ATP and accessory proteins. Embo J 23, 2664-2673. 
Hirano, M., and Hirano, T. (2006). Opening closed arms: long-distance activation of SMC 
ATPase by hinge-DNA interactions. Mol Cell 21, 175-186. 
Hirano, T. (2006). At the heart of the chromosome: SMC proteins in action. Nat Rev Mol Cell 
Biol 7, 311-322. 
References 78 
 
 
 
Hirano, T., Kobayashi, R., and Hirano, M. (1997). Condensins, chromosome condensation 
protein complexes containing XCAP-C, XCAP-E and a Xenopus homolog of the 
Drosophila Barren protein. Cell 89, 511-521. 
Hirano, T., and Mitchison, T. J. (1994). A heterodimeric coiled-coil protein required for 
mitotic chromosome condensation in vitro. Cell 79, 449-458. 
Hirota, T., Gerlich, D., Koch, B., Ellenberg, J., and Peters, J. M. (2004). Distinct functions of 
condensin I and II in mitotic chromosome assembly. J Cell Sci 117, 6435-6445. 
Hoeppner, S. (2005) Structure of the Mediator subunit Cyclin C and subunit interaction studies 
within the Mediator head module, PhD Thesis, LMU, Munich. 
Hopfner, K. P., Karcher, A., Craig, L., Woo, T. T., Carney, J. P., and Tainer, J. A. (2001). 
Structural biochemistry and interaction architecture of the DNA double-strand break 
repair Mre11 nuclease and Rad50-ATPase. Cell 105, 473-485. 
Hopfner, K. P., Karcher, A., Shin, D. S., Craig, L., Arthur, L. M., Carney, J. P., and Tainer, J. 
A. (2000). Structural biology of Rad50 ATPase: ATP-driven conformational control in 
DNA double-strand break repair and the ABC-ATPase superfamily. Cell 101, 789-800. 
Hopfner, K. P., and Tainer, J. A. (2000). DNA mismatch repair: the hands of a genome 
guardian. Structure 8, R237-241. 
Hopfner, K. P., and Tainer, J. A. (2003). Rad50/SMC proteins and ABC transporters: unifying 
concepts from high-resolution structures. Curr Opin Struct Biol 13, 249-255. 
Husain, I., Van Houten, B., Thomas, D. C., and Sancar, A. (1986). Sequences of Escherichia 
coli uvrA gene and protein reveal two potential ATP binding sites. J Biol Chem 261, 
4895-4901. 
Jun, S. H., Kim, T. G., and Ban, C. (2006). DNA mismatch repair system. Classical and fresh 
roles. Febs J 273, 1609-1619. 
Kabsch, W. (1993). Automatic processing of rotation diffraction data from crystals of initially 
unknown symmetry and cell constants. J Appl Cryst 21, 916-924. 
Karcher, A., Buttner, K., Martens, B., Jansen, R. P., and Hopfner, K. P. (2005). X-ray structure 
of RLI, an essential twin cassette ABC ATPase involved in ribosome biogenesis and 
HIV capsid assembly. Structure 13, 649-659. 
Kim, S. T., Xu, B., and Kastan, M. B. (2002). Involvement of the cohesin protein, Smc1, in 
Atm-dependent and independent responses to DNA damage. Genes Dev 16, 560-570. 
Kimura, K., and Hirano, T. (1997). ATP-dependent positive supercoiling of DNA by 13S 
condensin: a biochemical implication for chromosome condensation. Cell 90, 625-634. 
Kimura, K., and Hirano, T. (2000). Dual roles of the 11S regulatory subcomplex in condensin 
functions. Proc Natl Acad Sci U S A 97, 11972-11977. 
Kireeva, N., Lakonishok, M., Kireev, I., Hirano, T., and Belmont, A. S. (2004). Visualization 
of early chromosome condensation: a hierarchical folding, axial glue model of 
chromosome structure. J Cell Biol 166, 775-785. 
Kitagawa, R., Bakkenist, C. J., McKinnon, P. J., and Kastan, M. B. (2004). Phosphorylation of 
SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway. Genes Dev 
18, 1423-1438. 
Klein, F., Mahr, P., Galova, M., Buonomo, S. B., Michaelis, C., Nairz, K., and Nasmyth, K. 
(1999). A central role for cohesins in sister chromatid cohesion, formation of axial 
elements, and recombination during yeast meiosis. Cell 98, 91-103. 
Kleywegt, G. J. (1996). Use of non-crystallographic symmetry in protein structure refinement. 
Acta Crystallogr D Biol Crystallogr 52, 842-857. 
Kleywegt, G. J., and Jones, T. A. (1998). Databases in protein crystallography. Acta 
Crystallogr D Biol Crystallogr 54, 1119-1131. 
References 79 
 
 
 
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature 227, 680-685. 
Lamers, M. H., Perrakis, A., Enzlin, J. H., Winterwerp, H. H., de Wind, N., and Sixma, T. K. 
(2000). The crystal structure of DNA mismatch repair protein MutS binding to a G x T 
mismatch. Nature 407, 711-717. 
Larionov, V. L., Karpova, T. S., Kouprina, N. Y., and Jouravleva, G. A. (1985). A mutant of 
Saccharomyces cerevisiae with impaired maintenance of centromeric plasmids. Curr 
Genet 10, 15-20. 
LeMaster, D. M., and Richards, F. M. (1985). 1H-15N heteronuclear NMR studies of 
Escherichia coli thioredoxin in samples isotopically labeled by residue type. 
Biochemistry 24, 7263-7268. 
Lengronne, A., Katou, Y., Mori, S., Yokobayashi, S., Kelly, G. P., Itoh, T., Watanabe, Y., 
Shirahige, K., and Uhlmann, F. (2004). Cohesin relocation from sites of chromosomal 
loading to places of convergent transcription. Nature 430, 573-578. 
Lengronne, A., McIntyre, J., Katou, Y., Kanoh, Y., Hopfner, K. P., Shirahige, K., and 
Uhlmann, F. (2006). Establishment of sister chromatid cohesion at the S. cerevisiae 
replication fork. Mol Cell 23, 787-799. 
Lieb, J. D., Albrecht, M. R., Chuang, P. T., and Meyer, B. J. (1998). MIX-1: an essential 
component of the C. elegans mitotic machinery executes X chromosome dosage 
compensation. Cell 92, 265-277. 
Lieb, J. D., Capowski, E. E., Meneely, P., and Meyer, B. J. (1996). DPY-26, a link between 
dosage compensation and meiotic chromosome segregation in the nematode. Science 
274, 1732-1736. 
Locher, K. P., Lee, A. T., and Rees, D. C. (2002). The E. coli BtuCD structure: a framework 
for ABC transporter architecture and mechanism. Science 296, 1091-1098. 
Losada, A., and Hirano, T. (2005). Dynamic molecular linkers of the genome: the first decade 
of SMC proteins. Genes Dev 19, 1269-1287. 
Lowe, J., Cordell, S. C., and van den Ent, F. (2001). Crystal structure of the SMC head 
domain: an ABC ATPase with 900 residues antiparallel coiled-coil inserted. J Mol Biol 
306, 25-35. 
Lupas, A., Van Dyke, M., and Stock, J. (1991). Predicting coiled coils from protein sequences. 
Science 252, 1162-1164. 
Martinez-Balbas, M. A., Dey, A., Rabindran, S. K., Ozato, K., and Wu, C. (1995). 
Displacement of sequence-specific transcription factors from mitotic chromatin. Cell 
83, 29-38. 
Mascarenhas, J., Soppa, J., Strunnikov, A. V., and Graumann, P. L. (2002). Cell cycle-
dependent localization of two novel prokaryotic chromosome segregation and 
condensation proteins in Bacillus subtilis that interact with SMC protein. Embo J 21, 
3108-3118. 
McDonald, W. H., Pavlova, Y., Yates, J. R., 3rd, and Boddy, M. N. (2003). Novel essential 
DNA repair proteins Nse1 and Nse2 are subunits of the fission yeast Smc5-Smc6 
complex. J Biol Chem 278, 45460-45467. 
McPherson, A. (2001). Crystallization of Biological Macromolecules (New York: Cold Spring 
Harbor Laboratory Press ). 
Melby, T. E., Ciampaglio, C. N., Briscoe, G., and Erickson, H. P. (1998). The symmetrical 
structure of structural maintenance of chromosomes (SMC) and MukB proteins: long, 
antiparallel coiled coils, folded at a flexible hinge. J Cell Biol 142, 1595-1604. 
References 80 
 
 
 
Michaelis, C., Ciosk, R., and Nasmyth, K. (1997). Cohesins: chromosomal proteins that 
prevent premature separation of sister chromatids. Cell 91, 35-45. 
Milutinovich, M., Unal, E., Ward, C., Skibbens, R. V., and Koshland, D. (2007). A Multi-Step 
Pathway for the Establishment of Sister Chromatid Cohesion. PLoS Genet 3, e12. 
Morris, R. J., Perrakis, A., and Lamzin, V. S. (2003). ARP/wARP and automatic interpretation 
of protein electron density maps. Methods Enzymol 374, 229-244. 
Nasim, A., and Smith, B. P. (1975). Genetic control of radiation sensitivity in 
Schizosaccharomyces pombe. Genetics 79, 573-582. 
Nasmyth, K., and Haering, C. H. (2005). The structure and function of SMC and kleisin 
complexes. Annu Rev Biochem 74, 595-648. 
Niki, H., Imamura, R., Kitaoka, M., Yamanaka, K., Ogura, T., and Hiraga, S. (1992). E.coli 
MukB protein involved in chromosome partition forms a homodimer with a rod-and-
hinge structure having DNA binding and ATP/GTP binding activities. Embo J 11, 
5101-5109. 
Niki, H., Jaffe, A., Imamura, R., Ogura, T., and Hiraga, S. (1991). The new gene mukB codes 
for a 177 kd protein with coiled-coil domains involved in chromosome partitioning of 
E. coli. Embo J 10, 183-193. 
Obmolova, G., Ban, C., Hsieh, P., and Yang, W. (2000). Crystal structures of mismatch repair 
protein MutS and its complex with a substrate DNA. Nature 407, 703-710. 
Oh, E. Y., Claassen, L., Thiagalingam, S., Mazur, S., and Grossman, L. (1989). ATPase 
activity of the UvrA and UvrAB protein complexes of the Escherichia coli UvrABC 
endonuclease. Nucleic Acids Res 17, 4145-4159. 
Ono, T., Losada, A., Hirano, M., Myers, M. P., Neuwald, A. F., and Hirano, T. (2003). 
Differential contributions of condensin I and condensin II to mitotic chromosome 
architecture in vertebrate cells. Cell 115, 109-121. 
Oswald, C., Holland, I. B., and Schmitt, L. (2006). The motor domains of ABC-transporters. 
What can structures tell us? Naunyn Schmiedebergs Arch Pharmacol 372, 385-399. 
Otwinowski, Z. a. M., W. (1997). Processing of X-ray Diffraction Data Collected in 
Oscillation Mode Methods in Enzymology 276, 307-326. 
Phipps, J., Nasim, A., and Miller, D. R. (1985). Recovery, repair, and mutagenesis in 
Schizosaccharomyces pombe. Adv Genet 23, 1-72. 
Randak, C., and Welsh, M. J. (2003). An intrinsic adenylate kinase activity regulates gating of 
the ABC transporter CFTR. Cell 115, 837-850. 
Randak, C. O., and Welsh, M. J. (2005). Adenylate kinase activity in ABC transporters. J Biol 
Chem 280, 34385-34388. 
Riordan, J. R., Rommens, J. M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, 
J., Lok, S., Plavsic, N., Chou, J. L., and et al. (1989). Identification of the cystic fibrosis 
gene: cloning and characterization of complementary DNA. Science 245, 1066-1073. 
Sakai, A., Hizume, K., Sutani, T., Takeyasu, K., and Yanagida, M. (2003). Condensin but not 
cohesin SMC heterodimer induces DNA reannealing through protein-protein assembly. 
Embo J 22, 2764-2775. 
Scheffzek, K., Ahmadian, M. R., Kabsch, W., Wiesmuller, L., Lautwein, A., Schmitz, F., and 
Wittinghofer, A. (1997). The Ras-RasGAP complex: structural basis for GTPase 
activation and its loss in oncogenic Ras mutants. Science 277, 333-338. 
Shintomi, K., and Hirano, T. (2007). How are cohesin rings opened and closed? Trends 
Biochem Sci. 
Sixma, T. K. (2001). DNA mismatch repair: MutS structures bound to mismatches. Curr Opin 
Struct Biol 11, 47-52. 
References 81 
 
 
 
Skibbens, R. V., Corson, L. B., Koshland, D., and Hieter, P. (1999). Ctf7p is essential for sister 
chromatid cohesion and links mitotic chromosome structure to the DNA replication 
machinery. Genes Dev 13, 307-319. 
Smith, P. C., Karpowich, N., Millen, L., Moody, J. E., Rosen, J., Thomas, P. J., and Hunt, J. F. 
(2002). ATP binding to the motor domain from an ABC transporter drives formation of 
a nucleotide sandwich dimer. Mol Cell 10, 139-149. 
Steffensen, S., Coelho, P. A., Cobbe, N., Vass, S., Costa, M., Hassan, B., Prokopenko, S. N., 
Bellen, H., Heck, M. M., and Sunkel, C. E. (2001). A role for Drosophila SMC4 in the 
resolution of sister chromatids in mitosis. Curr Biol 11, 295-307. 
Sunako, Y., Onogi, T., and Hiraga, S. (2001). Sister chromosome cohesion of Escherichia coli. 
Mol Microbiol 42, 1233-1241. 
Takahashi, T. S., Yiu, P., Chou, M. F., Gygi, S., and Walter, J. C. (2004). Recruitment of 
Xenopus Scc2 and cohesin to chromatin requires the pre-replication complex. Nat Cell 
Biol 6, 991-996. 
Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994). CLUSTAL W: improving the 
sensitivity of progressive multiple sequence alignment through sequence weighting, 
position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673-
4680. 
Torres-Rosell, J., Machin, F., Farmer, S., Jarmuz, A., Eydmann, T., Dalgaard, J. Z., and 
Aragon, L. (2005). SMC5 and SMC6 genes are required for the segregation of 
repetitive chromosome regions. Nat Cell Biol 7, 412-419. 
Toth, A., Ciosk, R., Uhlmann, F., Galova, M., Schleiffer, A., and Nasmyth, K. (1999). Yeast 
cohesin complex requires a conserved protein, Eco1p(Ctf7), to establish cohesion 
between sister chromatids during DNA replication. Genes Dev 13, 320-333. 
Turck, D. (1992) Weiterentwicklung eines Programms fuer Molekuelgraphik und 
Elektronendichte-Manipulation und seine Anwendung auf verschiedene Protein-
Strukturaufklaerungen., PhD Thesis, Munich, Germany. 
Uhlmann, F. (2001). Secured cutting: controlling separase at the metaphase to anaphase 
transition. EMBO Rep 2, 487-492. 
Uhlmann, F., Lottspeich, F., and Nasmyth, K. (1999). Sister-chromatid separation at anaphase 
onset is promoted by cleavage of the cohesin subunit Scc1. Nature 400, 37-42. 
Uhlmann, F., Wernic, D., Poupart, M. A., Koonin, E. V., and Nasmyth, K. (2000). Cleavage of 
cohesin by the CD clan protease separin triggers anaphase in yeast. Cell 103, 375-386. 
Van Houten, B., Croteau, D. L., DellaVecchia, M. J., Wang, H., and Kisker, C. (2005). 'Close-
fitting sleeves': DNA damage recognition by the UvrABC nuclease system. Mutat Res 
577, 92-117. 
Vergani, P., Basso, C., Mense, M., Nairn, A. C., and Gadsby, D. C. (2005a). Control of the 
CFTR channel's gates. Biochem Soc Trans 33, 1003-1007. 
Vergani, P., Lockless, S. W., Nairn, A. C., and Gadsby, D. C. (2005b). CFTR channel opening 
by ATP-driven tight dimerization of its nucleotide-binding domains. Nature 433, 876-
880. 
Wakeman, T. P., Kim, W. J., Callens, S., Chiu, A., Brown, K. D., and Xu, B. (2004). The 
ATM-SMC1 pathway is essential for activation of the chromium[VI]-induced S-phase 
checkpoint. Mutat Res 554, 241-251. 
Walker, J. E., Saraste, M., Runswick, M. J., and Gay, N. J. (1982). Distantly related sequences 
in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-
requiring enzymes and a common nucleotide binding fold. Embo J 1, 945-951. 
References 82 
 
 
 
Watanabe, Y., and Nurse, P. (1999). Cohesin Rec8 is required for reductional chromosome 
segregation at meiosis. Nature 400, 461-464. 
Weeks, C. M., and Miller, R. (1999). Optimizing Shake-and-Bake for proteins. Acta 
Crystallogr D Biol Crystallogr 55, 492-500. 
Weitzer, S., Lehane, C., and Uhlmann, F. (2003). A model for ATP hydrolysis-dependent 
binding of cohesin to DNA. Curr Biol 13, 1930-1940. 
Yamanaka, K., Ogura, T., Niki, H., and Hiraga, S. (1996). Identification of two new genes, 
mukE and mukF, involved in chromosome partitioning in Escherichia coli. Mol Gen 
Genet 250, 241-251. 
Yamazoe, M., Onogi, T., Sunako, Y., Niki, H., Yamanaka, K., Ichimura, T., and Hiraga, S. 
(1999). Complex formation of MukB, MukE and MukF proteins involved in 
chromosome partitioning in Escherichia coli. Embo J 18, 5873-5884. 
Yazdi, P. T., Wang, Y., Zhao, S., Patel, N., Lee, E. Y., and Qin, J. (2002). SMC1 is a 
downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. 
Genes Dev 16, 571-582. 
Yoshimura, S. H., Hizume, K., Murakami, A., Sutani, T., Takeyasu, K., and Yanagida, M. 
(2002). Condensin architecture and interaction with DNA: regulatory non-SMC 
subunits bind to the head of SMC heterodimer. Curr Biol 12, 508-513. 
Young, L., Leonhard, K., Tatsuta, T., Trowsdale, J., and Langer, T. (2001). Role of the ABC 
transporter Mdl1 in peptide export from mitochondria. Science 291, 2135-2138. 
Zhao, X., and Blobel, G. (2005). A SUMO ligase is part of a nuclear multiprotein complex that 
affects DNA repair and chromosomal organization. Proc Natl Acad Sci U S A 102, 
4777-4782. 
Zimmerman, C., Klein, K. C., Kiser, P. K., Singh, A. R., Firestein, B. L., Riba, S. C., and 
Lingappa, J. R. (2002). Identification of a host protein essential for assembly of 
immature HIV-1 capsids. Nature 415, 88-92. 
 
Abbreviations 83 
 
 
 
9 Abbreviations  
Å Angstrom (1 Å = 10-10 m) 
ABC ATPase ATP-binding cassette ATP hydrolase 
ADP adenosine-5p-diphosphate 
AMP adenosine-5p-monophosphate 
AP5A P1,P5-di(adenosine-5’)pentaphosphate 
ATP adenosine-5p-triphosphate 
B.subtilis Bacillus subtilis 
bp base pair(s) 
C.elegans Caenorhabditis elegans 
cv column volume 
dsDNA double stranded deoxyribonucleic acid 
dNTP deoxynucleotide triphosphate 
DTT dithiothreitol 
E.coli Escherichia coli 
EDTA Ethylenediaminetetraacetic acid 
FT Fourier transformation 
g gramm 
g multiples of the earth's gravitational field (centrifugation) 
h hour 
IEX ion exchange chromatography 
IMAC immobilized metal affinity chromatography 
kDa kilo Dalton 
keV kilo electron Volt 
kT/e Boltzman's constant * 300 Kelvin / 1 electron charge 
LB Luria-Bertani 
M molar (mol / l) 
MAD multiple anomalous diffraction 
MES 2-(N-morpholino)ethanesulfonic acid 
MR moleculare replacement 
min minute 
NBD nucleotide binding domain 
OD optical density 
Pi inorganic phosphate 
PAGE polyacrylamide gel electrophoresis 
PCR polymerase chain reaction 
PEG polyethylene glycol 
Pfu Pyrococcus furiosus 
pI isoelectric point 
s second 
SAD single anomalous diffraction 
ScpA Segregation and condensation protein A 
ScpB Segregation and condensation protein B 
SDS sodium dodecyl sulfate 
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SMC structural maintenance of chromosomes 
SMCcd SMC catalytic domain 
SnB Shake’n’Bake 
T.maritima Thermotoga maritima 
TMD trans membrane domain 
Tris Tris(hydroxymethyl)aminomethane 
U unit 
v volume 
v/v volume per volume 
w weight 
w/v weight per volume 
wt wild type 
Appendix I 
Appendix 
Table 1: Components of eukaryotic SMC complexes 
(from (Losada and Hirano, 2005)) 
 
 
Appendix II 
 
Figure 42: Structure based sequence alignment of SMC proteins. 
Aligned SMC proteins from Pyrococcus furiosus (Pf), Thermatoga maritima (TM), Saccaromyces 
cerevisiae SMC1 (Sc) and human SMC1 and 2 (h1 / h2) with secondary structure elements 
(denoted as in Fig. 27) and conserved motifs. 
 
Appendix III 
Table 2: Crystallographic table of SMCcd and ATP-SMCcd 
Crystallographic data collection and analysis 
ATP free crystal form: unit cell (C2) (Å): a=102.3 b=56.7 c=78.9 α=90 β=123.0 γ=90 
     
Dataset peak inflection high native 
X-ray source PX (SLS) PX (SLS) PX (SLS) ID29 (ESRF) 
Wavelength (Å) 0.97913 0.97931 0.97121 0.91677 
Data range (Å) 40.0-2.5 40.0-2.5 40.0-2.5 40.0-2.0 
Observations (unique) 57254 (11997) 60450 (11782) 53270 (10847) 73963 (22600) 
Completeness (%) (last shell) 89.3 (51.9)a 87.0 (43.8)a 87.6 (17.1)a 88.3 (55.5) 
Rsymb   0.061 (0.105) 0.059 (0.142) 0.064 (0.188) 0.070 (0.182) 
     
ATP bound crystal form: unit cell (P3121) (Å): a=102.6 b=102.6 c=87.2 α=90 β=90 γ=120 
     
Dataset peak native   
X-ray source ID14-4 (ESRF) PX (SLS)   
Wavelength (Å) 0.97931 0.97547   
Data range (Å) 40-2.8 40.0-2.5   
Observations (unique) 178626 (16351) 98474 (18600)   
Completeness (%)  98.7 (94.8)a 99.5 (95.2)   
Rsymb   0.080 (0.429) 0.054 (0.366)   
     
Refinement ATP bound ATP free   
Data set native native   
Data range (Å) 20.0-2.5 20.0-2.0   
Reflections F>0 (cross validation) 18583 (907) 22291 (1080)   
non-hydrogen atoms (solvent molecules) 2788 (210) 2748 (205)   
Rcrystc (Rfreed) 21.0 (26.9) 20.7 (26.1)   
Rms bond length (Å)/bond angles  0.009 (1.3) 0.019 (2.3)   
% core (disallowed) in Ramachandran plot 90.2 (0.0) 94.7 (0.0)   
     
a Anomalous completeness 
b Rsym is the unweighted R value on I between symmetry mates  
c Rcryst = ∑hkl║Fobs(hkl)│-│Fcalc(hkl)║/ ∑hkl│Fobs(hkl)│ 
d Rfree = the cross validation R factor for 5% of reflections against which the model was not refined 
 
 
 
 
 
 
 
 
Appendix IV 
Table 3: Crystallographic table of ADP-AlF4- and ADP-BeF3- bound SMCcd 
Crystallographic data collection and analysis 
Space group: P3(1)21 
unit cell AlF4-: a=120.12 Å b=120.12 Å c=86.88 Å α=90° β=90° γ=120° 
unit cell BeF3-: a=120.552 Å b=120.552 Å c=87.516 Å α=90° β=90° γ=120° 
 AlF4- BeF3-   
X-ray source PX (SLS) PX (SLS)   
Wavelength (Å) 0.9999 0.9999   
Data range (Å) 50.0-2.3 50-2.3   
Observations (unique) 126551 (21501) 107533 (23477)   
Completeness (%) (last shell) 91.1 (74.5) 97.9 (89.3)   
Rsyma (last shell) 0.046 (0.313) 0.050 (0.324)   
     
Refinement     
 AlF4- BeF3-   
Data range (Å) 20.0-2.3 20.0-2.3   
Reflections F>0 (cross validation) 21376 (1090) 22318 (1134)   
non-hydrogen atoms (solvent molecules) 2451 (194) 2612 (201)   
Rworkb (Rfreec) 23.0 (27.4) 20.6 (24.1)   
Rms bond length (Å)/bond angles  0.0122 / 1.6378 0.0136 / 1.5799   
% core (disallowed) in Ramachandran plot 90.7 (0.0) 92.0 (0.0)   
     
a Rsym is the unweighted R value on I between symmetry mates  
b Rwork = ∑hkl║Fobs(hkl)│-│Fcalc(hkl)║/ ∑hkl│Fobs(hkl)│ 
c Rfree = the cross validation R factor for 5% of reflections against which the model was not refined 
 
Table 4: Crystallographic table of AP5A-SMCcd 
Crystallographic data collection and analysis 
Space group: P2(1); unit cell: a=65.0Å b=86.1Å c=70.1Å α=90° β=116.6° γ=90° 
     
X-ray source ID14-2 (ESRF)    
Wavelength (Å) 0.933    
Data range (Å) 50.0-1.6    
Observations (unique) 306506 (82978)    
I / σ (last shell) 16.3 (3.8)    
Completeness (%) (last shell) 95.7 (83.0)    
Rsyma (last shell) 0.047 (0.255)    
     
Refinement     
Data range (Å) 20.0-1.6    
Reflections F>0 (cross validation) 79746 (4269)    
non-hydrogen atoms (solvent molecules) 5324 (727)    
Rworkb (Rfreec) 18.3 (21.4)    
Rms bond length (Å)/bond angles  0.198 (1.8)    
% core (disallowed) in Ramachandran plot 94.5 (0.0)    
     
a Rsym is the unweighted R value on I between symmetry mates  
b Rwork = ∑hkl║Fobs(hkl)│-│Fcalc(hkl)║/ ∑hkl│Fobs(hkl)│ 
c Rfree = the cross validation R factor for 5% of reflections against which the model was not refined 
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